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Abstract 
Child maltreatment is a potent relational pathogen that alters functioning across 
diverse developmental domains, and has been shown to increase risk for a host of mental 
health problems, including internalizing disorders. Similarities in the neuroendocrine 
profiles of individuals who develop internalizing symptoms and individuals who have 
been maltreated are striking, and suggest a role of neuroendocrine functioning, 
specifically the hypothalamic-pituitary-adrenal (HPA) axis, in the pathogenesis of 
internalizing disorders following child maltreatment. Risk and protective genetic factors, 
particularly relevant to HPA axis functioning, have been discovered, further highlighting 
involvement of the HPA axis and offering ideas about how some maltreated children may 
evade the biological impact of maltreatment. There has been movement in the field 
toward identifying mediators and moderators at multiple levels of analysis to best inform 
developmental mechanisms, which may ultimately aid in the treatment and prevention of 
deleterious outcomes following child maltreatment. Utilizing a large, ethnically 
homogenous sample, the current study employed exploratory and confirmatory factor 
analysis and structural equation modeling to examine associations among child 
maltreatment, risk across multiple HPA-related genes, daytime cortisol patterns, and 
internalizing symptoms in effort to clarify biological mechanisms. Results revealed that 
experiences of maltreatment prior to age 5 were most predictive of internalizing 
symptoms in African American youth, whereas maltreatment occurring at or after age 5 
was most predictive of HPA axis dysregulation in the form of blunted diurnal decrease of 
cortisol. Genetic factors did not alter the relationship between maltreatment and cortisol, 
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nor were genetic risk patterns reflected in HPA functioning. There was no mediation of 
the relationship between maltreatment and internalizing symptoms by HPA dysfunction. 
Results are interpreted through a developmental psychopathology lens, emphasizing the 
principle of equifinality, whereby children follow multiple pathways toward internalizing 
symptoms. Implications for future research, particularly the need for longitudinal studies 
in this area, are discussed.    
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Introduction 
Overview 
Child maltreatment represents an extreme failure of the evolutionary expected 
caregiving environment to provide basic emotional, physical, and/or psychological needs 
essential for optimal development (Cicchetti & Lynch, 1995). Maltreatment may involve 
acts of omission (failure to provide physical and/or emotional resources for the child) 
and/or commission (harmful acts inflicted upon the child), with subsequent implications 
for maturation (Cicchetti & Lynch, 1995). Extensive research with both humans and 
animals over the past four decades has shown that maltreatment is capable of inducing 
pervasive, deleterious effects across a number of developmental domains (Cicchetti & 
Lynch, 1995; Cicchetti & Toth, 2013; Cicchetti & Valentino, 2006). Disruptions in 
attachment, self-conceptualization, brain structure, brain function, neuroendocrine 
function, gene expression, emotion recognition, social cognition, information processing, 
executive functioning, self-regulation, social competence, and both peer and romantic 
relationships have all been linked to the experience of child maltreatment (see Cicchetti 
& Toth, 2015 for review). By way of developmental cascading effects, the impact of 
maltreatment on any one of these domains can transact with other levels of functioning 
and be carried forward across the lifespan to erode mental health (Masten & Cicchetti, 
2010).  
One mental health outcome frequently associated with child maltreatment is 
internalizing symptoms (Andersen & Teicher, 2008; Cicchetti & Rogosch, 2001b; Kim & 
Cicchetti, 2006; Manly, Kim, Rogosch, & Cicchetti, 2001; Widom, DuMont, & Czaja, 
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2007). Internalizing symptoms may include excessive guilt, sadness, isolation/social 
withdrawal, negative self-image, feelings of worthlessness/hopelessness, cognitive 
deficits (poor concentration and memory), irritability, anhedonia, avolition, fatigue, 
somatic complaints, autonomic arousal (e.g., rapid heart beat) changes in appetite, 
excessive worry, avoidance, rumination, or sleep disruption – all of which are captured 
by anxiety and depressive disorders as constructed in the Diagnostic and Statistical 
Manual of Mental Disorders, 5th Edition (DSM-5; American Psychiatric Association, 
2013). Children maltreated during or prior to the preschool years seem to be most 
vulnerable to developing these symptoms (Cicchetti, Rogosch, Gunnar, & Toth, 2010; 
Hart, Gunnar, & Cicchetti,1995; Kaplow & Widom, 2007; Keiley, Howe, Dodge, Bates, 
& Petit, 2001; Manly et al., 2001).  
Internalizing problems are of great concern given the personal and public health 
burden they present. Internalizing disorders are one of the leading contributors to 
disability worldwide (Murray & Lopez, 2002), and are associated with substantial 
impairment in several areas of functioning, including academic achievement, 
interpersonal relationships, employment, and financial stability (Rice & Miller, 1995; 
Wulsin & Singal, 2003). Even more, internalizing disorders such as major depressive 
disorder have been associated with higher prevalence of death by suicide, and have also 
been related to several chronic physical illnesses (e.g., arthritis, cardiovascular disease, 
diabetes), further contributing to increased mortality (Kessler, 2012). The development of 
internalizing problems earlier in life carries greater risk for experiencing chronic, 
recurrent psychopathology (Fombonne, Wostear, Cooper, Harrington, & Rutter, 2001), 
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disability (González et al., 2010; Mathers & Lancar, 2011), and poor physical health 
(Weissman et al., 1999) throughout the lifespan. Additionally, earlier-onset internalizing 
disorders are more likely to be accompanied by self-injury and behavior problems 
(Gomez, Vance, & Gomez, 2014; Jonsson et al., 2011; Maughan, Collishaw, & 
Stringaris, 2013). As such, it is important to understand the ways that maltreatment 
increases risk for internalizing problems in children as this information may help identify 
effective intervention targets and alleviate the tremendous impact on personal and public 
health.  
Maltreatment may enhance risk for internalizing problems through its effects on 
the hypothalamic-pituitary-adrenal (HPA) axis. The following sections of this 
introduction are organized in a way that will orient the reader to basic HPA functioning 
and regulation, and the variety of ways that maltreatment and internalizing symptoms 
interact with the HPA axis. First, background information on basic HPA functioning and 
physiology will be provided. Second, an overview of maltreatment and HPA functioning 
will be presented. Third, the ways by which disrupted neuroendocrine function may 
contribute to internalizing symptoms, and the neuroendocrine profiles of individuals with 
internalizing symptoms will be discussed. Fourth, the mechanistic role of HPA function 
and the specificity of maltreatment will be examined. Fifth, the contribution of 
moderating genetic factors will be considered. Finally, rationale, aims, and hypotheses of 
the current study will be specified.  
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Basic HPA Functioning and Physiology 
The HPA axis exists as one important component of a complex stress system 
network whose functioning allows organisms to meet environmental demands. Neural 
and hormonal signaling are responsible for initiating and inhibiting HPA activity. 
Generally, the HPA axis governs two relatively distinct processes: 1) mounting responses 
to and promoting recovery from acute stressors, and 2) maintaining a diurnal circadian 
cycle of hormone production to ensure appropriate arousal and restoration at different 
times of the day (Cone, Low, Elmquist, & Cameron, 2002). In these ways, HPA activity 
is critical to providing organisms with required resources to manage and respond to 
internal and external signals, and to maintain physiological stability.  
HPA axis activity is initiated once a stressor is detected.  Stressors may exist 
systemically (i.e., physical stress such as decreased blood pressure, low blood glucose, 
extreme temperatures) or psychologically (i.e., psychological threat as interpreted by the 
organism, recognized and processed by the corticolimbic system; Gunnar & Vasquez, 
2006). Thus, maltreatment may activate the HPA axis through pathways from internal 
organs that carry information about physical states, and through pathways that relay 
information regarding expectations and interpretations of threat. With regard to response 
to acute psychological stressors, the first step in the stress response is threat detection by 
various limbic brain regions (e.g., amygdala, hippocampus) which send activating signals 
to the paraventricular nucleus (PVN) of the hypothalamus. With systemic stressors, 
signals reach the PVN traveling across brainstem pathways. Signals from psychological 
and systemic pathways converge on the PVN, and, when strong enough, result in 
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secretion of corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) 
from the paraventricular nucleus (PVN) of the hypothalamus. A hormonal cascade 
follows, whereby CRH and AVP subsequently travel to the anterior pituitary to bind 
receptors on corticotrophic cells, causing cleavage of the proopiomelanocortin (POMC) 
molecule and, consequently, the release of adrenocorticotropic hormone (ACTH) into 
circulation. Finally, ACTH reaches the adrenal gland, binds receptors in the adrenal 
cortex, and triggers the release of glucocorticoids (cortisol in humans; corticosterone in 
rodents).  
Once released, cortisol acts on the body and brain to initiate a host of responses 
that allow for behavioral and physiological adaptations to stress, including: increasing the 
bioavailability of glucose, redistributing energy to vital targets (i.e., toward brain and 
muscles and away from non-essential biological processes such as digestion, physical 
growth, and reproduction), reducing inflammation, enhancing attention to the immediate 
environment, and facilitating defense-related learning and memory processes (reviewed 
in Gunnar, Doom, & Esposito, 2015). These effects of cortisol are essential for survival 
as they allow organisms to adaptively attend to the environment and have the energy to 
respond to and learn from threat exposure. Moreover, via the circadian diurnal cycle, 
controlled secretion of cortisol throughout the day allows organisms to have resources 
necessary to manage daily functions essential to health, such as metabolism, brain 
development, immune function, and cellular repair (Gunnar et al., 2015). Through the 
diurnal cycle, HPA activity also synchronizes other biological systems including hepatic, 
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circulatory, and respiratory systems, thus allowing for efficient functioning at a 
physiological level (Chung, Son, & Kim, 2011). 
Cortisol achieves its effects primarily through binding its receptors– the 
mineralocorticoid receptor (MR) and the glucocorticoid receptor (GR) – located in the 
cell’s cytoplasm and distributed throughout various areas of the brain and body (reviewed 
in Gunnar & Vasquez, 2006). Cortisol preferentially binds MRs (Wyrwoll, Homes, & 
Seckl, 2011), and will bind GRs when MRs are occupied or otherwise unavailable. Given 
that most MRs are occupied when basal cortisol levels are exceeded, GR activity is 
highest when cortisol levels surpass baseline, such as early in the day when the circadian 
cycle is at its peak and/or when an acute stressor is introduced. In this way, cortisol’s 
receptors work in concert to maintain basal levels and circadian production of cortisol 
throughout the day, and to manage responses to stress and regulation of the system back 
to baseline following stress exposure (see Gunnar & Vasquez, 2006).  
As can be seen, cortisol and other stress hormone production is necessary and 
critical for health. However, cortisol and its secretagogues can be extremely detrimental 
when uncontrolled, both when production is too high and too low. For example, high 
levels of cortisol and CRH can damage nerve cells (Ábrahám, Harkany, Horvath, & 
Luiten, 2001) and alter neural development in important regions of the brain such as the 
amygdala, hippocampus, and prefrontal cortex (PFC; Heim, Owens, Plotsky, & 
Nemeroff, 1997). Alternatively, when cortisol levels are too low, tissue responsivity to 
neurotransmitters is disrupted, and glucose is not adequately delivered to the brain (see 
Gunnar, et al., 2015). Further, both excessive and inadequate levels of cortisol hinders 
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expression of genes that promote neurogenesis and neuroplasticity, impeding cellular 
growth and development (see Gunnar & Vasquez, 2006). Thus, regulatory processes are 
paramount. 
Regulatory mechanisms to control HPA activity exist in many forms. One 
important mechanism includes negative feedback, whereby cortisol inhibits its own 
production by shutting down the release of its secretagogues. Negative feedback is 
accomplished through cortisol binding to GRs in the PVN, anterior pituitary, 
hippocampus, and medial PFC (reviewed by Gunnar & Vasquez, 2006). Therefore, once 
cortisol is produced, its presence signals inhibition of further production through receptor 
activity at various levels of the brain, demonstrating the importance of receptors to proper 
HPA functioning and regulation.  
Maltreatment and HPA Functioning 
The HPA axis is incredibly sensitive to social experiences (Dickerson & Kemeny, 
2004; Flinn & England, 1995). Social relationships both shape and serve to regulate HPA 
activity. Relationships with caregivers have been shown to influence HPA functioning 
such that children do not respond as highly to stressors when in the presence of 
supportive caregivers (Gunnar, Brodersen, Nachmias, Buss & Rigatuso, 1996; Hostinar, 
Johnson, & Gunnar, 2015; Nachmias, Gunnar, Mangelsdorf, Parritz & Buss, 1996; 
Spangler & Schieche, 1998). Thus, the caregiving relationship buffers children from 
stress and minimizes exposure to the potentially damaging effects of cortisol. Children 
with poor relationships with caregivers, however, are not buffered, even from relatively 
minor stressors (Gunnar & Donzella, 2002).  
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Understanding the capacity of caregivers to regulate HPA activity is relevant to 
understanding how and why child maltreatment may drastically shift HPA functioning. 
That is, maltreated children are not only unprotected from activation of the HPA axis by 
mild stressors, they are also likely to experience frequent and/or prolonged activation of 
the HPA axis due to their caregivers’ frightening and/or neglectful behavior. In this way, 
a maltreating caregiver’s behavior may program a child’s system to be stress-responsive, 
sending a message that the environment is not safe and will require an arsenal of HPA 
hormones for immediate survival. Evolutionarily, this type of programming is adaptive in 
the short-term, as it allows the child to meet the demands of an uncertain environment, 
and to build a behavioral repertoire that may allow him or her to quickly manage threat 
and evade harm. Over time, however, this sensitization of the system can be problematic 
given the negative consequences of exposure to dysregulated levels of stress hormones as 
discussed above. 
Preclinical research has consistently shown that maltreatment induces a stress-
reactive system. In rats and nonhuman primates, maltreatment promotes sustained release 
of CRH as well as increased ACTH and corticosterone output following stress exposure 
(Dent, Smith, & Levine, 2000; Gunnar & Vasquez, 2006; Pihoker, Owens, Kuhn, 
Schanberg, & Nemeroff, 1993). Increased circulating levels of CRH as well as increased 
CRH mRNA expression under resting conditions have similarly been found (Heim & 
Nemeroff, 1999). Moreover, reduced GR mRNA expression in the dorsal hippocampus 
and higher morning levels of corticosterone have been consistently demonstrated 
(Avishai-Eliner, Yi, Newth, & Baram, 1995; Francis, Diorio, Liu, & Meaney, 1999; Ivy, 
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Brunson, Sandman, & Baram, 2008; Liu et al., 1997; Plotsky & Meaney, 1993). With an 
abundance of CRH, ACTH, and corticosterone, as well as an attenuation of the inhibitory 
capacity of the GR, maltreated animal’s stress systems are designed to facilitate 
adaptation to high environmental demand. 
The idea that maltreatment sensitizes the HPA axis specifically toward a stress-
reactive state is not as clear from the child literature, in part because reactivity by way of 
psychosocial and pharmacologic challenge is not as easily tested in maltreated children, 
but also because a variety of confounding variables and other methodological constraints 
are introduced into these investigations. For example, measuring mRNA expression in 
brain tissue of children is not feasible. Similarly, samples of cerebrospinal fluid (where 
CRH can be measured) are not readily available for examination, precluding the ability to 
examine more central aspects of the HPA axis. Uncertainty about the true nature and 
timing of maltreatment, secondary to variable assessment procedures, introduces further 
limitations and sources of variability. Finally, many of the studies are cross-sectional and 
provide only a snapshot of HPA functioning during one specific point in time of a 
maltreated child’s life.  
That being said, HPA hyper-activity has been documented in some studies of 
maltreated children. For example, maltreated children have exhibited hyper-activity by 
way of increased reactivity to a separation paradigm and higher baseline cortisol levels 
(Bugental, Martorell, & Barraza, 2003). In addition to hyper-activity, other forms of 
disruption, including hypo-activity, have been found. Different groups of older children 
age 10-12 and 12-16 exhibited blunted responses to stressors (Fisher, Kim, Bruce, & 
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Pears, 2012; MacMillan et al., 2009; Peckins, Dockray, Eckenrode, Heaton, & Susman, 
2012). Other groups of older children (age 7-15) showed decreased ACTH secretion to a 
CRH challenge (De Bellis et al., 1994). Atypical diurnal rhythms (Cicchetti et al., 2010; 
Gunnar, Morison, Chisholm, & Schuder, 2001; Hart, Gunnar, & Cicchetti, 1995) 
characterized by lower morning cortisol (Bruce, Fisher, Pears, & Levine, 2009), higher 
evening cortisol (Hart, Gunnar, & Cicchetti, 1996; Kaplan, Pelcovitz, & Labruna, 1999; 
Kaufman et al., 1997), and minimal change in cortisol levels over the course of the day 
have also been documented.  
The adult literature predominantly points toward hypo-responsiveness and 
increased negative feedback of the HPA axis following child maltreatment, though there 
is also evidence of hyper-activity, especially for adults with internalizing symptoms, as 
discussed below. A critical meta-analysis of primarily cross-sectional studies revealed 
lower basal evening levels, stronger suppression of cortisol following administration of 
an artificial version (dexamethasone) of the hormone, and blunted responses to 
psychosocial stressors among adults who have experienced maltreatment (Miller, Chen, 
& Zhou, 2007). These findings suggest a compensatory down-regulation of the stress 
system, presumably as a result of chronic over-drive and hyper-activity earlier in life. 
This “attenuation hypothesis” is supported by the only published longitudinal 
neuroendocrine study spanning early childhood to young adulthood, where basal cortisol 
levels of abused girls were initially significantly higher than non-abused girls in 
childhood, but began decreasing in adolescence, and were substantially lower than non-
abused females during young adulthood (Trickett, Noll, Susman, Shank, & Putnam, 
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2010). As can be seen, maltreated individuals may initially demonstrate HPA hyper-
activity but may later demonstrate hypo-activity, suggesting that developmental timing is 
an important variable to consider when making sense of previous findings in the child 
literature. 
In sum, individuals who have been maltreated exhibit a variety of alterations to 
the organization of their stress response system and patterns of HPA axis activity. Some 
individuals appear to have higher levels of stress hormones when they theoretically 
should have lower levels, while others have lower levels than what is optimally required. 
These observations can differ as a function of methodological approaches, age group 
sampled, timing of maltreatment experiences, and a host of other factors (e.g., Banny, 
Cicchetti, Rogosch, & Oshri, 2013; Cicchetti et al., 2010; Davies, Sturge-Apple, 
Cicchetti, & Cummings, 2007; DeBellis & Zisk, 2014; Doom, Cicchetti, Rogosch, & 
Dackis, 2013; McCrory, De Brito, & Viding, 2010). Though a unitary neuroendocrine 
pattern is not uniformally observed, the important message is that deviations in hormone 
levels, whether too high or too low, reflect general disruption, and that both hyper- and 
hypo-activity can have negative consequences on health, with implications for 
internalizing symptoms (e.g., Tarullo & Gunnar, 2006).  
Relevance of HPA Dysfunction to Internalizing Symptoms 
HPA dysfunction in the form of altered hormone production has direct links to 
internalizing symptoms. For example, administration of CRH to rodents has been shown 
to have both immediate and delayed effects on behavior that strongly parallel 
internalizing symptoms, including increased physiological arousal (increased heart rate), 
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decreased food intake and feeding behavior, disruption of slow-wave sleep, restlessness 
(i.e., increased locomotion in familiar environments), suppressed exploratory behavior in 
novel environments, and increased distress vocalizations (reviewed by Heim & 
Nemeroff, 1999). Additionally, the structural brain changes that accompany exposure to 
elevated or suppressed stress hormones such as dendritic atrophy of the PFC, increased 
dendritic branching and activity of the amygdala, and reduced hippocampal 
volume/decreased branching of hippocampal pyramidal neurons (Makino, Gold, & 
Schulkin, 1994; Sullivan & Gratton, 2002; Ulrich-Lai & Herman, 2009) can shape 
cognition and emotion in ways consistent with internalizing disorders. Such cognitive and 
emotional patterns include hypervigilance, exaggerated startle, concentration difficulties, 
and altered processing of emotional information (e.g., Lupien, Gillin, Frakes, Soefje, & 
Hauger, 1995).  
Furthermore, decreased tissue responsiveness to neurotransmitters following 
chronically low levels of cortisol can impair functioning of relevant serotonergic and 
dopaminergic systems, possibly resulting in changes to reward and motivation (Goff & 
Tottenham, 2014; Gunnar et al., 2015). Lastly, the effects of cortisol on memory 
formation and consolidation can promote salience and recall of fear-related, emotionally-
arousing memories (e.g., Bryant, 2003; Cicchetti et al., 2010; Howe, Cicchetti, & Toth, 
2006, Roozendaal, 2000) at the expense of recalling neutral and positive information 
(Lupien, Maheu, Tu, Fiocco, & Schramek, 2007; Tops et al., 2003). Over time, such a 
pattern can skew perceptions of reality, and initiate and/or perpetuate negative moods.   
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Internalizing Symptoms and HPA Dysfunction 
Similar to maltreated individuals, those with internalizing symptoms exhibit HPA 
dysfunction. In humans, hyperactivity of the axis represented by elevated morning 
cortisol, flattened circadian patterns, and increased urinary free cortisol over the day have 
all been associated with internalizing symptoms (reviewed by Nestler et al., 2002). 
Hyperactivity is also evident in increased reactivity to stress among animals; rodents who 
exhibit increased glucocorticoid (corticosterone) response to restraint stress also exhibit 
features indicative of animal models of depression (see Gunnar & Quevedo, 2007 for a 
review). Additionally, longer and larger cortisol responses to acute stress in humans, as 
well as reduced ability for dexamethasone to suppress plasma cortisol levels are forms of 
hyperactivity observed in individuals with internalizing symptoms (e.g., Lopez-Duran, 
Kovacs, & George, 2009; Zobel et al., 2001). Failure to suppress to dexamethasone along 
with longer, larger responses to stress suggests that negative feedback is compromised in 
individuals with internalizing problems, likely leading to the HPA hyperactivity often 
observed in this population (Pariante & Lightman, 2008).   
In addition to elevated HPA activity, blunted HPA activity has also been 
associated with internalizing symptoms. For example, low basal cortisol levels were 
concurrently associated with emotional symptoms in 5th graders (Shirtcliff & Essex, 
2008). Additionally, children exhibiting an attenuated response to a psychosocial stressor 
also had increased emotional/behavioral problems (Ouellet-Morin et al., 2011). In a study 
of younger children, those at risk for depression demonstrated hyporesponsivity to a 
psychological stressor (Hankin, Badanes, Abela, & Watamura, 2010), though these 
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children were later hyperresponsive to the same psychological stressor when assessed in 
adolescence (Hankin et al., 2010).  
Mechanistic Role of HPA Dysfunction 
The fact that HPA disruption has been found to precede internalizing symptoms 
when assessed longitudinally points toward a mechanistic role of HPA disruption in the 
pathogenesis of internalizing disorders. Individuals without depressive symptoms but at 
risk for developing depression given family history have been shown to exhibit higher 
and more variable morning cortisol over a 10 day period (e.g., Halligan, Herbert, 
Goodyer, & Murray, 2004). This pattern of cortisol predicted depression onset several 
years later (Halligan, Herber, Goodyer, & Murray, 2007). Additionally, a higher cortisol 
awakening response (CAR) in the absence of depressive symptoms predicted onset of 
major depressive episodes 2.5 years later in adolescents (Vrshek-Schallhorn et al., 2013). 
In another study of adolescents, higher morning and afternoon cortisol levels 
prospectively predicted an increase in depressive symptoms over time (Heim & Binder, 
2012). 
Reversal of both neuroendocrine dysfunction and anxious and depressed behavior 
by pharmacologic manipulation of stress system regulators also supports a mechanistic 
role of HPA dysfunction in internalizing symptoms. In rodents, both depressive behavior 
and HPA hyperactivity have been reversed by pharmacologic agents that increase GR 
function (Weaver et al., 2004). The opposite can also be achieved. That is, rats who were 
characteristically “relaxed” were made to exhibit anxious and depressive behavior by 
pharmacologically shutting down function of the GR and decreasing its expression in the 
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brain (Weaver et al., 2004). Administration of antidepressants in humans has been shown 
to improve negative feedback and increase function and expression of GR, which 
correlates with improvements in depressive symptoms (Pariante & Lightman, 2008). 
Hyporesponsivity has been shown to normalize upon clinical recovery as well 
(Amsterdam et al., 1988). Taken as a whole, these findings offer good reason to speculate 
that HPA disruption contributes to internalizing symptoms.   
Despite a great deal of evidence of disrupted neuroendocrine function in 
individuals with internalizing symptoms, some do not exhibit HPA dysfunction at all. For 
example, Birmaher and colleagues (1996) found no association between depressive 
symptoms and HPA response to CRH challenge. Similarly, children with anxiety and/or 
depressive disorders did not display any evidence of dysregulation when their cortisol 
production was monitored over a 24h period (Feder et al., 2004). Additionally, waking 
cortisol, diurnal slope, and total cortisol output were unrelated to later onset of depression 
in adolescents (Adam et al., 2010). Such findings suggest that other factors may better 
account for the dysfunctional patterns of neuroendocrine function observed for some 
individuals with internalizing symptoms. Accumulating research has pointed toward 
maltreatment as being the missing link (e.g., Feder et al., 2004; Hart et al., 1996; Heim et 
al., 2000, 2001; Heim, Mletzko, Purselle, Musselman, & Nemeroff, 2008; Kaufman, 
1991). 
Specificity of Maltreatment 
In a landmark study, when examining four different groups of women with 
varying degrees of overlap between childhood abuse and internalizing symptoms (i.e., 
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women with both childhood abuse histories and depression; women with childhood abuse 
histories but without depression; women without abuse histories with depression; and 
women without abuse histories and without depression), Heim et al. (2000, 2001) found 
that only the women with abuse histories who also had depression exhibited increased 
production of cortisol to stress. These findings were replicated in later work by Heim and 
colleagues (2008) that showed depressed men with childhood abuse histories and current 
major depressive disorder diagnoses failed to suppress to the combined 
dexamethasone/CRH test (thus, cortisol levels were higher than they should be following 
this pharmacologic challenge), yet men with the same diagnosis without abuse histories 
did not evince this pattern of hyperactivity.  
Similar conditional associations of maltreatment, HPA dysfunction, and 
internalizing symptoms have been documented for children as well. Cicchetti and 
colleagues (2010) found that maltreated children exhibited a blunted decrease in cortisol 
over the course of the day, but only in the context of concurrent internalizing symptoms. 
Neither nonmaltreated children with internalizing symptoms nor maltreated children 
without internalizing symptoms exhibited this neuroendocrine dysfunction. Similarly, 
other groups have shown that children who have experienced maltreatment demonstrate 
atypically low morning cortisol and high evening cortisol (also reflecting a diurnal 
flattening, as Cicchetti and colleagues (2010) found), only if they also have high levels of 
depressive symptoms (Hart et al., 1996; Kaplan, Pelcovitz, & Labruna, 1999; Kaufman et 
al., 1997). 
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These seminal findings, combined with evidence from preclinical research on 
maltreatment, have led researchers to speculate about the specificity of HPA dysfunction 
in the development of internalizing symptoms following maltreatment. Because 
dysfunction is evident primarily in individuals with internalizing symptoms and 
maltreatment histories, it appears that maltreatment uniquely predisposes for internalizing 
symptoms because of its specific impact on HPA functioning. As such, maltreatment may 
operate through the HPA axis to increase risk for internalizing symptoms. Additionally, 
there may be specific classes of internalizing disorders that exist; some of which are 
secondary to HPA dysfunction (i.e., those observed in maltreated individuals) with others 
that come about via alternative avenues (i.e., those observed in nonmaltreated 
individuals). Different classes may require different treatments.  
Moderating Factors  
Notably, there are children who develop neither HPA dysfunction nor 
internalizing symptoms. Why are some maltreated children protected against 
neuroendocrine dysfunction and/or internalizing symptoms while others are not? 
Although there have been many proposed reasons (see, for example, Banny et al., 2013; 
Cicchetti et al., 2010; Davies et al, 2007; DeBellis & Zisk, 2014; Doom et al., 2013; 
McCrory et al., 2010), genetic variation is particularly relevant to the current study. If a 
child possesses a version of a gene that alters the way they biologically respond to stress, 
the impact of maltreatment on HPA function may be favorably attenuated or 
unfortunately enhanced.   
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With this in mind, several researchers have investigated the relative contribution 
of stress-related genes to internalizing symptoms in the context of child maltreatment and 
have found significant associations (e.g., Binder et al., 2004; Bradley et al., 2008; 
Cicchetti & Rogosch, 2014; Cicchetti, Rogosch, & Oshri, 2011; Liu et al., 2006; 
Polanczyk et al., 2009). Among the genes, four are particularly common:  FKBP5, 
CRHR1, NR3C1, and NR3C2 (Kuningas et al., 2007; Lavebratt, Åberg, Sjöholm, & 
Forsell, 2010; Lekman et al., 2008; Liu et al., 2006; van West et al., 2006) and will be 
briefly reviewed herein (see Method section for more detailed information on these genes 
and their involvement in HPA function).  
A single nucleotide polymorphism (SNP; rs110402; see Table 2 for a glossary of 
genetic terms) in the CRHR1 gene that was previously implicated in differential HPA 
response to stress paradigms altered risk for developing depression in maltreated adults 
(Bradley et al., 2008; Heim et al., 2009; Polanczyk et al., 2009). When part of a 
haplotype, this SNP also enhanced risk for internalizing symptoms in maltreated children 
and, further, interacted with other genes to amplify risk in maltreated carriers relative to 
maltreated non-carriers (Cicchetti & Rogosch, 2014; Cicchetti et al., 2011). Variation in 
FKBP5, a gene whose product has been shown to reduce the ability for cortisol to bind 
GR (Klengel et al., 2013), has also been linked to diverse associations among 
maltreatment and internalizing symptoms. One particular SNP (rs1360780) promoting 
increased FKBP5 function (thus, reduced GR activity) has consistently been found to 
increase risk for depressive symptoms exclusively in maltreated individuals, both 
children and adults, possessing this variant (Zannas & Binder, 2014).  
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Similarly, SNPs in genes coding for cortisol’s receptors, GR and MR (NR3C1 and 
NR3C2 genes, respectively), differentially enhance risk for internalizing symptoms or 
endophenotypes of internalizing symptoms (i.e., amygdala reactivity) in maltreated 
individuals. In a group of adolescents, a functional SNP in the MR gene that was 
previously shown to increase reactivity of the HPA axis to stress, enhanced amygdala 
reactivity to threat among those reporting earlier childhood abuse (Bogdan, Williamson, 
& Harriri, 2011). With regard to the GR gene, few gene-environment interaction studies 
examining maltreatment, specifically, have been conducted, but several focusing more 
broadly on environmental adversity have shown associations. One study examining a 
SNP (BclI) associated with reduced cortisol production found increased 
emotional/behavioral problems for carriers of the minor allele who also experienced 
childhood adversity (Velders et al., 2012). Other indicators (i.e., DNA methylation) of 
functional change to the GR resulting in reduced activity have been examined with regard 
to internalizing symptoms in maltreated children. One study found that increased 
methylation of the GR gene partially mediated the effect of early adversity (including 
maltreatment) on internalizing problems (Parade et al., 2016). Taken together, it appears 
that factors operating at the genetic level can increase or decrease the likelihood that a 
maltreated individual will exhibit internalizing symptoms or its correlates, presumably 
given the alterations in HPA axis functioning that these variants confer.  
The Current Study 
Study rationale 
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Despite much speculation that HPA axis dysfunction may operate as a mechanism 
by which child maltreatment uniquely contributes to internalizing symptoms, and despite 
the belief that the relative impact of maltreatment on internalizing symptoms is dependent 
on genetic factors associated with differential activity of the HPA axis, no previous 
studies have examined these variables together in one model. Rather, a piecemeal 
approach has typically been executed. That is, some studies have examined maltreatment, 
HPA-related genes, and HPA function, but have only speculated about the implications 
for internalizing symptoms, framing HPA dysfunction as an endophenotype of 
internalizing symptoms (e.g., Heim et al., 2009; Tyrka et al., 2009). Conversely, other 
studies have examined maltreatment, HPA-related genes, and internalizing symptoms, 
but have only speculated about HPA functioning, using the candidate genes and their 
previously-established associations with HPA functioning as proxies for actual HPA 
function in the sample (Bradley et al., 2008; Grabe et al,. 2010; Zimmermann et al., 
2011). Finally, other studies have examined maltreatment, HPA function, and 
internalizing symptoms, but have not considered genetic contributions (e.g., Cicchetti et 
al., 2010; Ouellet-Morin et al, 2011). One study that attempted to examine all variables 
together (Cicchetti et al., 2011) was ultimately unable to given cell size constraints as a 
function of sample characteristics. Thus, building a moderated mediation model will help 
clarify the nature of these relationships in ways that previous studies could not.  
Focus on Early Maltreatment 
In humans, fear-related neural systems are undergoing drastic construction 
especially during the first years of life (Thompson & Nelson, 2001); therefore, 
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maltreatment occurring during this formative period of development can greatly affect 
the way neural systems are structured. Indeed, maltreatment (like cortisol) is associated 
with changes in size and dendritic branching of the amygdala, hippocampus, and PFC 
(De Bellis et al., 1999, 2002; Heim et al., 2008; Petchtel, Lyons-Ruth, Anderson, & 
Teicher, 2014; Ulrich-Lai & Herman, 2009), and there is evidence that the amygdala is 
particularly sensitive to early experiences of adversity (Pechtel & Pizzagalli, 2011). 
Animal models have provided direct and causal evidence that timing is critical by 
demonstrating that the structural and functional brain changes that follow maltreatment 
during the first week of life persist and manifest as increased physiological and 
behavioral responses to stress throughout development (see Kaffman and Meaney, 2007; 
Lupien et al., 2009; Meaney et al., 1996). Studies in children have also highlighted the 
importance of timing, revealing that only children maltreated early in life exhibit HPA 
dysfunction and internalizing symptoms (Cicchetti et al., 2010). Thus, the theoretical 
relevance of timing to limbic brain development and neuroendocrine function as well as 
support from previous studies with children provides justification for the focus on early 
timing of maltreatment. 
Although other aspects of maltreatment, most prominently the type of 
maltreatment experienced, have emerged as important predictors of the effect of 
maltreatment on internalizing symptoms and HPA function (e.g., Bradley et al., 2008; 
Cicchetti et al., 2010; Hart et al., 1996; Heim et al., 2009), it has recently been suggested 
that all forms of maltreatment are relatively equally damaging. That is, in a sample of 
over 2,200 maltreated children, different types of maltreatment were shown to have 
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similar effects on the development of internalizing symptoms (Vachon, Krueger, 
Rogosch, & Cicchetti, 2015). Thus, in effort to be most parsimonious, subtype as well as 
additional features of maltreatment were not of primary focus in the current investigation.  
Internalizing Symptoms vs. Specific Disorder 
Psychopathology has been broadly characterized by two main factors: 1) 
internalizing symptoms, and 2) externalizing symptoms (Krueger, 1999). An outcome 
variable combining various measures to broadly capture internalizing symptoms was thus 
considered more appropriate than constraining to one specific disorder cluster. Further, 
children in the current study were primarily between the ages of 8-10. Measures geared 
toward a specific disorder, such as depression, would likely be an inadequate 
representation of internalizing problems given that depressive disorders, singularly, are 
less likely to fully emerge before adolescence (Kessler et al., 2005). As such, 
internalizing symptoms, rather than a particular disorder, were of focus in the current 
study. 
Diurnal Change 
Although there are several ways to examine HPA function such as reactivity to 
and recovery from a psychosocial and/or pharmacologic stressor, examining reactivity 
was not possible given available archival data and the questionable ethics of inducing 
stress in maltreated children, particularly those currently experiencing maltreatment. 
Moreover, although hyperactivity has been frequently associated with maltreatment and 
internalizing symptoms, diurnal blunting has been documented more often in studies of 
children (e.g., Dozier et al., 2006; Fisher, Gunnar, Dozier, Bruce, & Pears, 2006).  
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Multigenic Risk Score 
As noted above, multiple genes involved in HPA functioning have been found to 
moderate the relationship between maltreatment and internalizing symptoms. Capturing 
risk across a variety of genes relevant to the system will better represent the HPA axis in 
its entirety, rather than focusing on one “string” in the symphony orchestra. Thus, in 
effort to examine the HPA system as a whole, a multigenic risk index was utilized. 
Rationale for considering the particular genes and SNPs used in the mutligenic risk score 
is presented in the Method section.   
Externalizing Symptoms as a Covariate 
The focus of the current study is understanding biological mechanisms underlying 
the development of internalizing symptoms, specifically. However, there is often a great 
deal of overlap between internalizing and externalizing symptoms (Wiggins, Mitchell, 
Hyde, & Monk, 2015). Additionally, different patterns of diurnal activity have been 
found for internalizing and externalizing symptoms (Bernard, Zwerling, & Dozier, 2015). 
Thus, failure to control for externalizing symptoms could cloud results of the current 
study. Understanding the nature of HPA axis disruption that is more specific to 
internalizing symptoms rather than comorbid internalizing/externalizing or externalizing, 
exclusively, could guide treatment efforts for different populations. For these reasons, the 
decision to focus on internalizing symptoms while controlling for externalizing 
symptoms was made.  
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Study Aims 
 
1. Clarify the nature of the relationship among maltreatment, genetic factors, HPA 
axis functioning, and internalizing symptoms to better understand potential 
biological mechanisms involved in the development of internalizing symptoms in  
maltreated children.  
 
2. Evaluate how genetic risk, as represented by a risk score, interacts with 
maltreatment to impact cortisol production across the day.  
Hypotheses 
 
1. Children maltreated before age 5 will have higher levels of internalizing 
symptoms than later maltreated and nonmaltreated children. 
 
2. Children maltreated before age 5 will have less change (i.e., blunted diurnal 
pattern) in cortisol from morning to evening compared to later and nonmaltreated 
groups. 
 
3. The relationship between early maltreatment and internalizing symptoms will be 
mediated by cortisol function, such that the indirect effects of early maltreatment 
on cortisol and cortisol on internalizing symptoms will best explain the 
relationship between early maltreatment and internalizing symptoms.  
 
4. Genetic risk will moderate the impact of maltreatment on cortisol functioning 
such that early maltreated children with the highest genetic risk scores will have 
the least amount of change in cortisol across the day. 
 
Method 
Participants  
The current study combines participants who attended research camps between 
the years 2004-2012. During their time at camp, children were involved in a variety of 
research projects, all of which were focused on examining the impact of childhood 
maltreatment and other risk factors on psychopathology. Maltreated (n = 373; 47% 
female) and nonmaltreated (n = 366; 53% female) children with available genetic, 
neuroendocrine, and internalizing symptom data were culled into one racially/ethnically 
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homogenous sample (N = 739). African American children were of exclusive focus for 
this study given 1) the importance of using a racially homogeneous sample when 
conducting genetic association studies to avoid population stratification issues, 2) the lack 
of comprehensive information on the development of internalizing symptoms in 
maltreated African American children, and 3) the relatively larger proportion of African 
American children attending the summer camps.  
Children ranged in age from 8 to 12 years (M age = 10.37, SD = 1.31); however, 
most (69%) of the children were between the ages of 8-10 years. All children were from 
predominantly low-income, disadvantaged families (90% received Temporary Assistance 
for Needy Families; TANF). Given study hypotheses and previous findings of greater 
impact of early maltreatment on HPA axis functioning (Cicchetti et al., 2010, 2010), 
maltreatment groups were subdivided into those maltreated early in life (before age 5; n = 
263), those maltreated later in life (age 5 and beyond; n = 110), and nonmaltreated 
children (n = 366). Maltreatment groups differed by gender and age; thus, both variables 
were added to the structural model in order to control for potential confounding effects. 
Table 1 lists demographic characteristics of each maltreatment group.  
Procedure 
Family Recruitment  
All study procedures were approved by the University of Rochester Institutional 
Review Board. Informed consent was obtained from parents of all participants. Child 
assent was also acquired prior to a child’s participation. Maltreating families were 
recruited with the assistance of a Department of Human Services (DHS) liaison. Thus, all 
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maltreated children had documented experiences of child maltreatment on file with the 
New York DHS. The DHS liaison contacted a random sample of identified maltreating 
families to explain purposes and procedures involved with the research study. Interested 
parents signed consent for the liaison to release their contact information to the research 
team and to allow for comprehensive examination of their DHS record files. 
Nonmaltreated children were recruited from families receiving TANF. Families receiving 
TANF were of focus given their low-SES characteristics and the intention to create a 
demographically-matched comparison group, in order to remove socioeconomic status 
(SES) as a confound. A DHS liaison contacted nonmaltreating families and provided the 
contact information of interested families to the research team following consent. All 
families were free to withdraw from participation of the study at any time without 
penalty. 
Data collection 
All children attended a week-long (7 hrs/day for five days), research-based 
summer camp program on one occasion between the years 2004-2012. Within the camp 
context, children were divided into groups of eight; approximately half of the children in 
each group were maltreated. All groups were composed of children of the same age and 
gender. Each group was led by three trained camp counselors unaware of maltreatment 
status and hypotheses of the study (see Cicchetti & Manly, 1990, for detailed descriptions 
of camp procedures). Trained research assistants, also unaware of maltreatment status 
and study hypotheses, administered research measures/questionnaires to children during 
the course of the week and collected salivary cortisol and DNA samples, as detailed 
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below. Children also participated in a variety of recreational activities throughout the 
week. Clinical support by licensed providers at Mt. Hope Family Center was available for 
any emerging concerns regarding a child’s danger to self or others.  
Measures 
The measures listed below represent only a subset of assessments administered 
during the camp program that are relevant to the current study’s research questions. 
Information was obtained by multiple informants (i.e., self-, parent-, and counselor-
report) and multiple methods (questionnaires, validated report measures, biological 
sampling).  
Demographics 
Parents (typically mothers) reported on child race and also specified their child’s 
Latino/Hispanic ethnicity as None, Puerto Rican, Cuban, Mexican, Dominican, or Other. 
Race/ethnicity was coded into a single variable using the Add Health system of coding 
race and ethnicity (DeYoung et al., 2011). To further characterize race/ethnicity, a SNP 
panel of 106 ancestry-informative genetic markers (AIMS) was used to classify children 
into African, European, or Native American descent (see Table 2 for more information 
regarding AIMS and other genetic terms). This method of classification is a standard 
typically used to determine ancestry (Lai et al., 2009; Yaeger et al., 2007). Ultimately, the 
decision regarding inclusion of children into the current study’s African American 
sample was based on the proportion of African ancestry a child possessed (i.e., children 
with African AIMS proportion scores at or above 0.6 were included; AIMS information 
was not available for 1.3% of the larger sample) rather than parent-reported 
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race/ethnicity. However, for a majority of children (97%), ancestral characterization 
overlapped with parent-reported race/ethnicity.  
Maltreatment 
Thorough searches of DHS records by the research team yielded maltreatment 
information, which was coded by trained research assistants, doctoral students, and 
clinical psychologists using the Maltreatment Classification System (MCS; Barnett, 
Manly, & Cicchetti, 1993; Cicchetti & Barnett, 1991b). Maltreatment classifications 
generated using the MCS were independent of DHS case designations. The MCS has 
been shown to be a highly reliable and valid method of classifying maltreatment 
experiences (Bolger, Patterson, & Kupersmidt, 1998; English et al., 2005), and considers 
various aspects of maltreatment including type of maltreatment, severity of each 
maltreatment incident, developmental period during which maltreatment began, number 
of developmental periods over which maltreatment occurred (chronicity), and frequency 
of occurrence of each maltreatment subtype.  
Onset of maltreatment was originally coded as infancy (0-18 months), 
toddlerhood (19-35 months), preschool (36-59 months), early school (5-7 years), later 
school (8-12 years), and adolescence (13-18 years). For the current study, these onset 
designations were combined in effort to group children into early (before age 5: infancy, 
toddlerhood, or preschool) or late (age 5 or later: early school, later school, and 
adolescence) maltreatment given the low number of children across more specific 
designations and the general view that the first few years of life are most sensitive for the 
development of limbic areas of the brain known to influence and regulate the stress 
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response (e.g., Thompson & Nelson, 2001). Maltreatment variables were dummy coded 
into early, late, and nonmaltreatment groups such that nonmaltreated children were the 
reference group.  
A trained research assistant interviewed identified nonmaltreating mothers using 
the Maternal Maltreatment Classification Interview (Cicchetti, Toth, & Manly, 2003) to 
verify that the family did not have undocumented experiences of maltreatment. 
Additionally, DHS records were examined a year following camp completion to confirm 
continued absence of maltreatment in the family. If families received DHS preventative 
services due to concerns for risk of maltreatment, or if any other questions regarding 
possible maltreatment arose, then those families were excluded from the current study.  
Internalizing Symptoms 
Internalizing symptoms were assessed using four measures. Two of the 
internalizing measures (Revised Checklist for Manifest Anxiety Scale (RCMAS) and 
Children’s Depression Inventory (CDI), see below for description) focused on specific 
internalizing disorders (i.e., depression and anxiety) and their respective diagnostic 
structures/symptom domains, while the remaining measures (Child Behavior Checklist 
Teacher Report Form (CBCL TRF) and Positive and Negative Affect Schedule-Child 
version (PANAS-C), see below for description) captured general features (i.e., 
withdrawal, somatic complaints, positive and negative affect) of internalizing problems.  
Because the goal was to broadly examine internalizing symptoms given the 
relevance of stress system functioning to various internalizing domains as well as 
heightened risk for general internalizing problems for maltreated individuals, a latent 
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variable across the various measures was created. When possible, overall scores for each 
measure rather than specific subscale scores (as described below) were used to create the 
internalizing symptoms latent variable. Only in the case of the PANAS-C were separate 
subscales (positive affect vs. negative affect) utilized, given that a combination of 
subscales (e.g., an overall affect score) was not feasible or meaningful for this measure.  
RCMAS 
Level of total anxiety symptoms were assessed using the RCMAS (Reynolds & 
Richmond, 1985). The RCMAS is a 37-item, self-report instrument with good reliability 
(internal consistency = .85; Reynolds & Richmond, 1978) designed to assess the level 
and nature of anxiety in children ages 6 to 19 years. Children answered a series of yes/no 
questions regarding different symptoms of anxiety, including social anxiety, general 
worry, and physiological symptoms of anxiety. A total anxiety T-score was generated. 
High scores indicated higher levels of anxiety, with T-scores greater than 60 indicating 
clinically significant anxiety concerns. Children in the current sample had mean total 
anxiety T-scores of 45.43 (SD = 11.17, range = 18-80). Total anxiety T-scores were used 
to create the internalizing latent variable. 
CDI  
The CDI (Kovacs, 1982, 1992) is a 27-item self-report measure regarding various 
depressive symptoms that school-age children report experiencing over the past 2 weeks. 
Internal consistency for the total scale has been reported from .71 to .89 (Kovacs, 1982). 
Although depressive symptoms are the primary focus of the CDI, the instrument 
reportedly measures a broad, multidimensional construct that overlaps with other 
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childhood disorders, especially anxiety disorders (Saylor, Finch, Spirito, & Bennett, 
1984). Symptom areas include negative mood (sadness, tearfulness, worry, difficulty with 
decision-making), interpersonal problems (problems with social interaction), 
ineffectiveness (negative evaluation of performance and ability), anhedonia (loss of 
interest, low energy, trouble sleeping, changes in appetite), and negative self-esteem 
(self-dislike, feeling of being unlovable).  
Each item is rated on a scale of 0 to 2, with 2 indicating the highest level of 
difficulty associated with the symptom. One item of the measure directly assesses 
suicidal ideation. For the current study, if a child endorsed this item, the child was 
evaluated by a licensed clinician at the Mount Hope Family Center. Clinicians were 
always on duty during camp hours. An overall depression score is provided, which can 
range from 0-54. Scores of 19 and above reflect clinically significant concerns (Kovacs, 
1992). Scores greater than 36 reflect severe depression (Stanley et al, 2009). In the 
current sample, total depression scores ranged from 0 to 48 (M = 7.57; SD = 6.94). Total 
depression scores were used to create the internalizing latent variable.  
PANAS-C 
The PANAS-C (Laurent et al., 1999) was used to obtain both child- and 
counselor-reported information regarding general affective states of each child. The 
measure has demonstrated good internal consistency (.86-.90 for Negative Affect (NA) 
scale; .84-.87 for Positive Affect (PA) scale; Watson, Clark, & Tellegen, 1988). The PA 
and NA scales have also demonstrated both convergent and discriminant validity with 
other self-report measures of childhood anxiety and depression (Laurent et al., 1999). The 
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NA scale, in particular, is thought to best capture individuals experiencing both anxiety 
and depression, given that emotional distress is a core component of these internalizing 
symptoms (Clark & Watson, 1991). 
Using a 5-point Likert scale (1 = very slightly to 5 = extremely), raters indicated 
how often 30 different feelings and emotions (15 descriptors for positive affect and 15 for 
negative affect) were outwardly exhibited or personally experienced by the child. PA 
included descriptors such as interested, alert, excited, active, proud, and daring. NA 
included descriptors such as sad, frightened, upset, jittery, and lonely. The highest 
possible score across items for each scale is 75.  Mean scores across all 15 items are 
obtained for each scale; thus the maximum mean score for each scale is 5. For the PA 
scale, higher scores reflect higher positive affect. Mean (SD) counselor-reported PA in 
the current study was 3.38 (.61); mean self-reported PA was 3.99 (.76). For the NA scale, 
higher scores reflect higher negative affect. Mean (SD) counselor-reported NA in the 
current study was 1.47 (.39); mean self-reported NA was 1.92 (.77). Mean scores for each 
scale were used to create the internalizing latent variable.  
TRF 
The TRF (Achenbach, 1991) is a 118-item measure that is widely used and 
empirically validated for the assessment of frequency (i.e., never, sometimes, often) of 
behavioral and emotional disturbance (both internalizing and externalizing symptoms) 
from teachers’ perspectives. In the current study, camp counselors were able to observe 
similar behaviors as teachers and were thus used in lieu of teachers given the proximity 
and extent of interaction between the counselors and children within the summer camp 
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context. The TRF has demonstrated variable reliability, especially for the internalizing 
scale (.56 to .84), which reflects the difficulty that observers have in rating the internal 
states of children (Achenbach, 1991). Three camp counselors rated each child on the 
TRF; counselors’ scores were averaged to obtain one score for each subscale. The overall 
internalizing T score (M = 47.67, SD = 7.91; range = 36-76) captures three aspects of 
internalizing symptoms, withdrawal, somatic complaints, and anxiety/depression, and 
was used to create the internalizing latent variable.  
Exploratory Factor Analysis 
Prior to conducting exploratory factor analysis (EFA), correlations were examined 
to assess the relative relationships among the various measures (see Table 3 for 
correlations among internalizing measures and other study variables). Correlations 
generally suggested a weak relationship between self- and counselor-reported measures 
and stronger correlations within self- and counselor-reported measures. Given a lack of 
certainty about the underlying factor structure/dimensionality of the data and whether 
measures could be meaningfully combined to create an internalizing latent variable, an 
EFA was run on a portion of the data. A random sample (n = 369) from the full dataset 
(N = 739) was selected to create a training sample with which the EFA was performed. 
Together, all self- and counselor-report indicators of internalizing symptoms, as listed 
above, were used to conduct the EFA using Geomin (oblique) rotation (i.e., factors were 
allowed to correlate). Due to skewness of some of the variables (CDI, self-reported NA, 
self-reported PA, counselor-reported NA, and TRF internalizing), separate EFA with 
transformed and untransformed variables were run. The model using the transformed 
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variables did not improve model fit, so untransformed variables were used in subsequent 
analyses with full-information maximum-likelihood (fiml) as an estimator. Number of 
factors was determined using standardized factor loading values and eigen values ≥ 1.0.  
To assess the goodness of fit of the EFA-generated model, the comparative fit 
index (CFI), Tucker-Lewis index (TLI), and root mean squared error of approximation 
(RMSEA) were examined. Values close to 1 for both TLI and CFI indicate good fit, 
while an RMSEA of .06 or less is often considered good fit (Bentler, 1990; Hu & Bentler, 
1999).  These guidelines were used to determine model fit for the current study.  
Confirmatory Factor Analysis  
The EFA-identified factor structure was validated on the remaining half of the 
sample. Thus, to confirm results of the EFA, a confirmatory factor analysis (CFA) using 
a 2-factor structure with oblique rotation and full information maximum likelihood 
estimator was run on the testing sample. After confirming the measurement model, a 
measurement invariance model was examined to determine whether the internalizing 
latent variables were operating similarly between males and females.  
Externalizing Symptoms  
Given the substantial overlap that often occurs between internalizing and 
externalizing symptoms (e.g., Essex et al., 2011), the significant (though weak) 
correlation between self- and other-reported internalizing and externalizing symptoms in 
the current study (r = .326 and .153, respectively), and the focus of the current study on 
contributions of maltreatment and stress system dysfunction solely to the development of 
internalizing problems, the externalizing problem scale of the TRF was used as a 
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covariate for both counselor-reported and self-reported internalizing symptoms. The TRF 
(Achenbach, 1991, see above description) was exclusively used to indicate externalizing 
problems as self-report measures of externalizing problems were not available. 
Aggression, attention problems, and rule-breaking behaviors comprised the overall 
externalizing T-score (M = 53.56, SD = 9.37; range = 39-82.5), which was used in 
analyses.  
HPA Functioning 
Cortisol Collection  
Saliva samples were obtained within the camp context each morning upon arrival 
to camp at 9am, at midday (noon), and each afternoon prior to camp departure at 4pm to 
provide information about daily cortisol production. Three samples were consistently 
collected at 9am, noon, and 4pm across the camp week, resulting in a maximum of 15 
total samples collected per child. All children experienced a 45-min bus ride before 
arriving to camp each day. Travel time to camp in addition to time spent being greeted by 
camp staff ensured that sample collection occurred consistently at least 1 hour after 
awakening, thus avoiding capturing cortisol values associated with the cortisol 
awakening response. Food or drink was not consumed for at least 30 min prior to saliva 
sample collection. Children chewed sugarless, Trident gum to facilitate saliva production 
and then deposited saliva through a straw into a plastic vial. Following collection, saliva 
samples were immediately stored at -40°C. Samples were later shipped overnight for 
assaying in duplicate by Salimetrics Laboratories (State College, PA) using an enzyme 
immunoassay (with assay sensitivity parameters ranging from 0.0007µg/dl to  1.8µg/dl 
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with 5% and 10% intra- and inter-assay coefficient variation, respectively). Cortisol 
production across the daytime period proxies the regulatory capacity of the HPA axis. Of 
note, daytime cortisol production patterns as used in this study are not equivalent with the 
diurnal cortisol rhythm. Wake time, cortisol awakening response, and bedtime values 
were not collected as part of the current study, precluding the ability to completely 
measure diurnal cortisol patterns.  
Cortisol Change Variable  
Mean raw cortisol values (in µg/dl) across camp days were as follows: M morning 
cortisol = 0.197, SD = 0.110; M noon cortisol = 0.123, SD = 0.054; M afternoon cortisol 
= .103, SD = 0.046. Morning samples were available across all five camp days for 58% 
of children, noon samples were available across all five camp days for 69% of children, 
and afternoon samples were available across all five camp days for 68% of children. A 
majority (97%) of children had at least 3 samples for each time point. Three children 
were missing all cortisol samples for morning, noon, and afternoon across all days. Given 
the large number of cortisol samples available per child and the intention of examining 
patterns of cortisol production from morning to evening, latent growth curve modeling 
was considered as a method to create the best-fitting slope across several data points. 
However, when cortisol values were collapsed across days, and morning, noon, and 
afternoon time points were plotted, values did not follow a linear pattern, thus eliminating 
this option. Instead, change in cortisol levels from morning to evening across the day was 
captured by a difference score.  
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To create the difference score, raw cortisol values were winsorized at 3 standard 
deviation values for the day/time in order to reduce the impact of outliers. Cortisol values 
were then log-transformed (log10) due to skewness. Log values were averaged across the 
five days for each morning and afternoon time points. For cases that did not have all data 
points per time period, available values were used to calculate the mean. The mean, log-
transformed morning value (M morning cortisol = -.785, SD = .216) was subtracted from 
the mean, log-transformed afternoon value (M afternoon cortisol = -1.055, SD = .183) to 
create the cortisol difference score. Negative cortisol difference values represent a greater 
change from morning to evening, which reflects more typical cortisol production patterns 
whereby levels decline over the course of the day. Cortisol difference score values closer 
to zero thus represent a “flattening” of the typical morning-to-afternoon pattern (M 
difference score = -0.269, SD = 0.176; range = -0.82-0.36).  
Genetic Risk 
DNA Collection, Extraction, and Genotyping 
Oragene collection kits and/or Epicentre Catch-All Collection Swabs were used to 
obtain saliva and/or buccal swab DNA samples, respectively. Buccal cells and saliva are 
both commonly used for genotyping DNA; both sources of DNA collection yield quality 
product. For buccal cells, DNA was extracted and prepared for polymerase chain reaction 
(PCR) amplification using the Epicentre BuccalAmp DNA Extraction Kit (Epicentre, 
Cat. No. BQ090155C). For saliva, DNA was purified from 0.5 ml of Oragene-DNA 
solution using the DNA genotek protocol for manual sample purification using prepIT-
L2P. Sample concentrations were quantified using the Quant-iT PicoGreen dsDNA 
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Assay Kit (P7589, Invitrogen). Applied Biosystems Custom Taqman SNP Genotyping 
Assays were used for single nucleotide polymorphism (SNP) genotyping. TaqMan 
procedures were performed on several gene variants. Genotypes were identified and 
sequenced with the Beckman-Coulter CEQ8000 semiautomated fluorescent sequencing 
system, which utilizes Fragment Analysis Application and associated software. To ensure 
quality control, all samples were genotyped in duplicate. In addition, human DNA control 
samples purchased from Coriell Cell Repositories were used for each genotype. Samples 
that were not able to be genotyped to a 95% or greater confidence level were repeated 
under the same procedures up to four times. 
Risk Index 
Nine variants across four stress-system genes (CRHR1, FKBP5, NR3C1, and 
NR3C2) were used to create a multigenic index of risk. All SNPs included in the 
multigenic risk index were chosen given their involvement in regulation of HPA axis 
activity (see below). Additionally, selected SNPs were a function of available archival 
data. A multigenic index was used in order to consider variation across several genes 
relevant to a neurobiological system rather than one particular aspect of the system. By 
using information regarding linkage disequilibrium (LD), and by examining genotype 
distributions, relevant, available SNPs were narrowed down from thirteen to nine in effort 
to reduce LD and given lack of variation in genotype. LD reflects non-independence of 
various alleles. Predictive accuracy of polygenic risk scores decreases among linked 
genotypes (Vilhjalmsson et al., 2015). Thus, efforts to reduce LD were made in order to 
avoid collinearity among SNPs so that different SNPs within each gene could be more 
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effectively represented. Eliminated SNPs included rs6195, rs6189/6190 of the NR3C1 
(GR) gene and rs3800373 of the FKBP5 gene. Within the NR3C1 (GR) gene, children in 
the current sample lacked variation in genotypes such that 99% of children were 
homozygous for the risk allele in the case of rs6195 and 99% of children were 
homozygous for the non-risk allele in the case of 6189/6190. The final SNP (rs3800373 
of FKBP5) was eliminated given documented high LD with rs1360780 (Binder et al., 
2004; Paggliaccio et al., 2014).  
Genotypes were coded based on characterization of risk alleles for each SNP (see 
below for decision-making process). In some cases (rs7209436, rs110402, rs242924 of 
CRHR1 gene; rs2070951 of NR3C2 gene), individuals homozygous for the identified risk 
allele were coded as “1,” while individuals heterozygous for risk were grouped with those 
homozygous for the non-risk allele and coded as “0.” In other cases (rs5522 of NR3C2 
gene; rs41423247 of NR3C1 gene; rs9296158, rs1360780, rs9470080 of FKBP5 gene), 
individuals with any risk allele (i.e., homozygous or heterozygous for risk allele) were 
coded as “1,” while those homozygous for the non-risk allele were coded as “0.” That is, 
for the former group, a recessive model was adopted for coding whereas, for the latter, a 
dominant model was utilized.  
Number of risk genotypes across all nine SNPs were summed (maximum score = 
9) to create a multigenic risk score, where higher scores reflected higher number of risk 
genotypes previously associated with HPA axis dysregulation. Investigations comparing 
utility of summing risk scores across SNPs versus including SNPs in a haplotype have 
found no bias in the former approach (Paggliaccio et al., 2014). If a child had four or 
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fewer genotypes missing across the nine SNPs, a prorated risk score was calculated by 
counting the number of risk genotypes and dividing by the total number of available data 
points to determine percentage of risk, and applying that percentage to nine to determine 
overall risk score. For example, if a child was missing 3 genotypes and thus had 6 of 9 
genotypes available, 3 of which were risk genotypes, then 3/6, or 50%, of genotypes were 
risk genotypes. Therefore, 50% of 9 (i.e., 4.5) was used as the overall multigenic risk 
score.  
Multigenic risk scores were mean-centered to remove multi-colinearity. One child 
was missing 5 or more genotypes, and, as such, was excluded from analyses. For each 
SNP, Hardy Weinberg Equilibrium (HWE) was calculated. Deviation from HWE was 
observed for rs2070951. The magnitude of the p-value for this SNP suggests that this 
deviation is not of substantial concern (see Turner et al., 2011), obviating the need to 
exclude or explore this subgroup in further analyses. All other SNPs were in HWE. 
Neither individual SNPs nor the overall multigenic risk score were related to 
maltreatment status. See Table 4 for allele frequencies and coding summary.  
Gene/SNP Selection and Coding Rationale 
The primary focus of this study was to explore HPA axis functioning as a 
biological mechanism through which child maltreatment contributes to the development 
of internalizing symptoms. Although there have been associations of several of the SNPs 
included in this study with internalizing symptoms and/or interaction with abuse or other 
environmental stressors to predict internalizing psychopathology, these aspects were 
ultimately not considered when creating the coding system for genetic risk given an effort 
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to isolate functional risk, that is, risk in the form of direct impact on biological 
functioning. Given that both attenuated and enhanced cortisol/ACTH levels (either as 
response to stress or with respect to basal levels) are considered maladaptive (e.g., 
Tarullo & Gunnar, 2006), alleles were classified as risk given their demonstrated impact 
on both reduced and increased cortisol/ACTH levels in healthy individuals. Functioning 
in healthy individuals was emphasized due to confounding effects that concurrent 
psychopathology has on HPA axis functioning.  
CRHR1 
CRH binding to its receptor provides the signal necessary to transduce neural 
input into a cortisol response (Rivier & Plotsky, 1986). CRHR1 is the primary receptor 
for CRH, and its activation by CRH has been found to increase ACTH and cortisol 
responses to stress as well as fear-related behaviors (e.g. Stenzel-Poore, Heinrichs, 
Rivest, Koob, & Vale 1994; Timpl et al., 1998). CRH over-expression has also been 
shown to increase basal levels of cortisol (Labermaier et al., 2014). Additionally, both 
increased CRHR1 expression and ligand binding attributable to genetic variation in the 
gene have been linked to prolonged elevation of cortisol following stress, whereas a 
CRHR1 antagonist reversed this same neuroendocrine pattern in mice (Timpl et al., 
1998). Similarly, in humans, reduced functioning of the CRHR1 receptor can normalize 
HPA axis responses to stress by reducing reactivity (Binder & Nemeroff, 2010; Hauger, 
Risbrough, Brauns, & Dautzenberg,  2006). Therefore, given its role in initiating the 
stress response and amplifying and prolonging HPA axis activation, the CRHR1 gene was 
selected. 
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rs7209436 
Although many studies have demonstrated links between various SNPs within the 
CRHR1 gene and adverse mental health outcomes both dependent and independent of 
environmental risk (e.g., Bradley et al., 2008; Cicchetti et al., 2010, 2011; Liu et al., 
2006; Tyrka et al., 2009), very few have actually investigated the direct impact of SNPs 
on HPA axis functioning in healthy individuals. In studies finding interactions between 
maltreatment and rs7209436 on psychopathology, the T allele was implicated as the risk 
allele. The notion that the T allele is the risk allele with respect to HPA axis functioning 
was supported in the one known study investigating the impact of rs7209436 on cortisol 
reactivity in healthy children. That is, preschool children carrying the T allele within a 
haplotype had marginally higher reactivity to a psychosocial stressor (Sheikh, Kryski, 
Smith, Hayden, & Singh, 2013). Thus, there is emerging evidence that rs7209436 
enhances risk by heightening responsivity of the HPA axis to stress. However, given lack 
of robust evidence to date demonstrating an effect of the T allele on HPA functioning, a 
recessive genetic model was utilized when coding risk in the current study. That is, only 
individuals homozygous for the T allele were coded as “1,” which represents a more 
conservative approach to coding risk as it requires individuals to possess both alleles 
previously linked to altered functioning.  
rs110402 
The A allele of CRHR1 rs110402 has been shown to predict increased cortisol 
levels in children in response to a laboratory stressor when part of a multigenic index 
utilizing a recessive model (Pagliaccio et al., 2014). Others have found that the A allele is 
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associated with attenuated response to stress (TSST) in healthy adults without psychiatric 
disorders (Mahon, Zandi, Potash, Nestadt, & Wand, 2013). In this study, all types 
(additive, dominant, recessive) of models were tested, and a recessive model emerged as 
the most appropriate underlying model. As a result, a recessive model was utilized to 
code the rs110402 SNP in the current study.  
rs242924 
In a study investigating variability in rs242924 and cortisol response in healthy 
adults, those homozygous for the T allele were nominally hyporesponsive to a stressor 
(Mahon et al., 2013). This is the only known study directly examining the impact of the 
rs242924 SNP on HPA axis functioning. As such, a conservative recessive model was 
used for coding genotypes.  
NR3C1 
Through binding its receptor, cortisol impacts various HPA axis functions, 
including both onset and termination of the stress response. The NR3C1 gene codes for 
the GR, which serves as the primary regulatory component of the stress reaction (de 
Kloet, Joels, & Holsboer, 2005). Altered GR availability and/or signaling has been shown 
to contribute to disrupted negative feedback inhibition of the HPA axis, leading to 
insufficient suppression of CRH and AVP release from the hypothalamus and ACTH 
from the pituitary, resulting in high levels of cortisol and maladaptive physical and 
mental health outcomes (see Zanas & Binder, 2014, for review).  The GR is needed to 
control HPA axis inhibition; without GR expression, exaggerated HPA responses and 
decreased feedback sensitivity are observed (e.g., Lupien, McEwen, Gunnar, & Heim, 
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2009; Weaver et al., 2004). By increasing the number and responsivity of GR receptors, 
endocrine profiles can be restored (Binder, 2009), thus demonstrating the profound 
control that GR has in influencing HPA axis functioning and highlighting its relevance to 
the current investigation.  
rs41423247 
Variability in rs41423247 (aka BclI) has been linked to altered cortisol sensitivity 
and variable stress responses. Individuals homozygous for the minor G allele (which 
produces a long fragment) have demonstrated elevated cortisol concentrations in response 
to stress (Rosmond et al., 2000), and a trend toward lower GR affinity for and sensitivity 
to dexamethasone in leukocyte cells (Panarelli et al., 1998) when compared to major 
allele homozygotes. In a study of children that included rs41423247 as part of a genetic 
profile score utilizing a dominant coding model (GG/GC vs. CC), children with higher 
profile scores had higher cortisol output before, during, and after a stressor (Pagliaccio et 
al., 2014). In another study of young men, a differential effect of number of minor alleles 
was observed such that minor allele heterozygotes demonstrated higher responses to 
stress compared to major allele homozygote controls, while minor allele homozygotes 
evinced significantly lower responses (Wust et al., 2004). Kumsta et al. (2007) identified 
sex-specific effects of genotype which could account for Wust et al.’s finding. Kumsta et 
al. (2007) demonstrated that although men homozygous for the minor allele had blunted 
stress responses, cortisol responses were heightened in women homozygous for the minor 
allele. Notably, all women in the Kumsta (2007) study were using oral contraceptives, 
which may account for findings.  
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Ising and colleagues (2008) found a dose-response effect (suggesting an additive 
model) of the minor allele such that individuals homozygous for the risk allele had lowest 
levels of anticipatory cortisol preceding a stressor, followed by minor allele 
heterozygotes, with major allele homozygotes having highest anticipatory cortisol levels. 
Higher anticipatory cortisol may reflect adaptive preparation of the system, while lower 
levels can indicate failure to mobilize necessary resources. Contrary to Kumsta’s study, 
the attenuating effect of the minor allele on anticipatory stress did not differ between 
males and females in Ising’s study. Lower than expected cortisol levels have also been 
found in a handful of studies reflecting super-suppression of the system following 
exposure to cortisol analogues. These studies have shown that both G-allele 
heterozygotes and homozygotes of both sexes show hypersensitivity of GR to cortisol 
based on increased suppression to dexamethasone (Stevens et al., 2004; van Rossum et 
al., 2003).  
Despite the suggestion of enhanced, rather than reduced negative feedback – 
which is more commonly cited as an indicator of dysfunction and has also been found for 
the minor allele of  rs41423247 by Rosmond et al. (2000) – for minor allele carriers, 
increased sensitivity of GR to cortisol is also problematic as it leads to vulnerability for 
increased CRH production in limbic regions (Reul & Holsboer, 2002; Schulkin, Gold, & 
McEwen, 1998). Additionally, it has been suggested that increased sensitivity of the GR 
receptor to cortisol may reflect underlying increased effect of cortisol on cells in these 
individuals (Weaver, Hitman, & Kopleman, 1992), meaning cortisol may be more 
powerful and, potentially, have greater impact on tissues in these individuals. From this 
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perspective, the G allele would continue to function as a “risk” allele. Although there 
have been various findings depending on sex, tissue type, and genotypic model, the only 
study relevant to children utilized a dominant model (Pagliaccio et al., 2014). For this 
reason, a dominant model of coding was used in the current study.    
FKBP5 
Function of the GR depends on various chaperone proteins binding to the receptor 
complex to either increase or decrease its functioning. The FKBP5 gene is a negative 
regulator of GR function making it a relevant and necessary candidate gene in this study, 
particularly with regard to its impact on negative feedback. FKBP5 codes for a protein, 
FKBP51, which binds to other proteins of the GR complex and changes GR signaling by 
reducing GR’s interaction with transport proteins, impeding nuclear translocation of the 
receptor, and creating a receptor structure that has a lower affinity for cortisol (Chrousos 
et al., 1982; Denny, Valentine, Reynolds, Smith, & Scammell, 2000). With such changes 
to GR activity, important negative feedback mechanisms which rely on cortisol binding 
to GR and serve to restrain HPA activity are affected, thereby leading to elevated cortisol 
levels. Preclinical data has demonstrated glucocorticoid resistance and elevated levels of 
cortisol in primates who naturally have high levels of FKBP5 (Bamberger, Shulte, & 
Chrousos, 1996; Chrousos et al., 1982; Chrousos et al., 1986), and, conversely, 
hypersensitivity of GR to corticosterone in animals that have lost function of the FKBP5 
gene (Touma et al., 2011). Furthermore, because cortisol induces production of FKBP5 
by binding to FKBP51 protein (Zannas & Binder, 2014), additional FKBP5 is produced 
in the presence of elevated cortisol, thus perpetuating the cycle.  
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rs1360780 
The minor A allele of the rs1360780 SNP is associated with higher FKBP5 
induction and reduced GR sensitivity (Binder et al., 2004; Klengel et al., 2013). Studies 
have shown that healthy adult carriers of the minor allele exhibit prolonged cortisol 
responses to stressors with insufficient/slower recovery to baseline (Buchmann et al., 
2014; Ising et al., 2008), and non-suppression of the HPA axis to dexamethasone (Touma 
et al., 2011). Healthy Dutch infants with the minor allele have also demonstrated 
increased cortisol following a minor stressor – the Strange Situation Paradigm (Luijk et 
al., 2010) – regardless of their attachment security classification. Notably, infants with 
insecure attachment showed even further negative effects on cortisol following stress, 
capturing the true diathesis present in the minor allele (i.e., altered stress response), 
where effects are further enhanced in the presence of a second vulnerability factor (i.e., 
insecure attachment – a proxy for poor parenting). These features indicate inadequate 
termination of the stress reaction secondary to GR resistance, a hallmark feature of 
depression, and suggest risk for exacerbated cortisol production in response to stress.  
In some of the studies (i.e., Ising et al., 2008; Luijk et al., 2010) the effect of the 
minor allele was examined individually (AA vs. AG vs. GG). Other studies (i.e., Touma 
et al., 2011) utilized a recessive model. Most often, only individuals homozygous for the 
minor allele showed effects on HPA axis functioning, with no differences between minor 
allele heterozygotes and major allele homozygotes, suggesting a recessive model of 
operation of the “risk” allele (i.e., need both risk alleles for an effect). However, in 
Buchmann’s 2014 study, both minor allele homozygotes and heterozygotes demonstrated 
   48 
 
similar effects on function with no difference between these genotypes but significant 
differences compared to major allele homozygotes, suggesting a dominant model of 
operation (i.e., need only one risk allele for an effect). In another study utilizing 
rs1306780 as part of a genetic profile score, consistent with Buchmann et al. (2014), 
individuals were dichotomized in accordance with a dominant model (i.e., AA/AG = 1; 
GG = 0) In this study (Pagliaccio et al., 2014), higher genetic profile scores were 
associated with higher cortisol levels in children aged 8-12 in response to a LabTAB 
stressor. In contrast, Luijk et al. (2010) found an additive main effect of genotype on 
cortisol such that cortisol reactivity increased in magnitude across genotypes as number 
of minor alleles increased (i.e., AA > AG > GG). As can be seen, there are differences 
across findings and approaches to coding. In order to be consistent with the only known 
study utilizing rs1360780 as part of a genetic profile score with children, the decision to 
follow a dominant genotypic coding model was made. 
rs9296158 
Despite extensive study of rs1306780, much less has been documented regarding 
other SNPs in the FKBP5 gene. Of those that have been investigated, rs9296158 has been 
shown to have an impact on HPA axis activity in healthy individuals. The A allele has 
been found to increase FKBP5 protein and mRNA expression (Binder et al., 2004). 
Among psychiatric controls, A allele carriers had higher cortisol levels post-
dexamethasone treatment, reflecting GR resistance (Binder et al., 2008). In this study, a 
dominant model was examined whereby A allele homozygotes and heterozygotes were 
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found to be similarly high in cortisol levels following dexamethasone administration. 
Thus, a dominant model was utilized to code rs9296158 genotypes in the current study.  
rs9470080 
Individuals carrying the T allele have been found to have increased FKBP5 
mRNA and protein levels as well as less suppression to dexamethasone than individuals 
homozygous for the major C allele (Binder et al., 2004, 2008). Thus, individuals with 
either one or two copies of the T allele have demonstrated impaired negative feedback. 
As such, a dominant coding scheme was used to classify rs9470080 genotypes in the 
current study.  
NR3C2 
The NR3C2 gene codes for cortisol’s other receptor – the MR. The MR has a high 
affinity for cortisol, thus, in the brain, cortisol more readily binds MR than GR. As such, 
cortisol is bound to MR under basal conditions, and, in this way, MR acts to maintain 
baseline function while creating a stress activation threshold. MR functioning is therefore 
important for maintaining tonic inhibition of HPA axis activity (e.g., Ratka, Sutanto, 
Bloemers, & de Kloet,  1989). Studies have suggested that MR haplotypes linked to 
higher MR expression and lower basal cortisol also exhibit more efficient onset of HPA 
activity and lower perceived stress (van Leeuwen et al., 2011). Conversely, loss of MR 
expression coincides with less sensitivity to ACTH (van Eekelen, Rots, Sutanto, Oitzl, & 
De Kloet,  1991). Furthermore, in the absence of typical MR function, basal cortisol 
levels increase and individuals are more stress-reactive (Arvat et al., 2001; Heuser et al., 
2000). Thus, effective MR action serves an important role in maintaining homeostasis 
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and regulating a healthy and dynamic stress response, making it a relevant gene to 
include as part of the multigenic risk index in the current investigation.  
rs5522 
Variability in the MR gene is linked with variable stress responses in healthy 
individuals. The rs5522 SNP (aka I180V) is located in an area involved in transcription 
and has a functional impact on amino acid production (Bogdan, Pagliaccio, Baranger, & 
Hariri, 2016). Individuals who carry the minor G allele of rs5522 produce the amino acid 
valine instead of the more typical amino acid leucine. This change affects the MR such 
that it is less functional in the presence of cortisol (Derijk et al., 2006). Additionally, 
minor allele carriers exhibit increased plasma and salivary cortisol output in response to 
psychosocial stressors (Derijk et al., 2006; Dickerson & Kemeny, 2004). Risk variant 
carriers have also been found to have higher baseline ACTH and higher cortisol during 
recovery periods following stress exposure (Ising et al., 2008). In these studies, a 
dominant genotype model was utilized such that any individual carrying a minor allele 
(val/val; CC or val/iso; CT) showed significant difference from individuals homozygous 
for the major allele (iso/iso; TT). As such, a dominant model was used to code rs5522 
risk in the current study.  
rs2070951 
The G allele of the rs2070951 SNP has been associated with reduced cellular 
response to cortisol and less MR protein expression (van Leeuwen et al., 2011). 
Compared to individuals heterozygous for the G allele or non-carriers, G allele 
homozygotes also demonstrate greater total cortisol output as measured by AUC (Muhtz, 
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Zyriax, Bondy, Windler, & Otte, 2011). Additionally, individuals carrying the G allele 
have higher basal cortisol levels (Kuningas et al., 2007). In some studies, G allele carriers 
were compared against non-carriers, suggesting a dominant model, while, in other 
studies, only homozygotes evinced changes in HPA function, suggesting a recessive 
model. In effort to be most conservative, a recessive model was used in the current study.  
Results 
Data Analytic Plan  
The primary analyses for the current investigation included factor analysis and 
structural equation modeling. For both strategies, the R statistical program version 3.3.1 
was used. First, EFA and CFA were conducted to build and verify the measurement 
model, creating the latent variables. Model invariance to gender was examined for the 
measurement model to ensure the latent variables were operating similarly for males and 
females in the sample. Once the measurement model was optimized, latent variables were 
used as dependent variables in a structural equation model with maltreatment status (early 
vs. late vs. non) as the dummy-coded independent variable, cortisol production as a 
mediator of the relationship between maltreatment and internalizing symptoms, 
multigenic risk as a moderator of the impact of maltreatment on cortisol slope, and 
counselor-reported externalizing symptoms as predictors of internalizing symptoms - in 
order to control for the effect of comorbid externalizing symptoms in the model. Gender 
and age were added to the structural model to control for confounding effects given 
unequal distribution of gender and age across maltreatment groups. The structural model 
was then examined relative to a multi-group model in order to determine whether 
separate structural models for males and females fit the data better than the structural 
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model treating males and females equally. Follow-up analyses were conducted to help 
understand the nature of original findings. These analyses were carried out using SPSS v. 
22 or the R statistical package. First, differences in mean morning and mean afternoon 
cortisol values among groups were tested to understand the nature of the cortisol 
flattening results. Next, results were examined with regard to severity of internalizing 
symptoms. Chronicity of maltreatment and its overlap with early and late onset of 
maltreatment were also examined. Finally, given differences in the literature regarding 
approach to coding genetic risk, three additional types of coding schemes were tested to 
examine the effect of different coding approaches on the original results.  
Exploratory Factor Analysis 
Of all seven internalizing symptom indicators (RCMAS, CDI, self-reported PA, 
self-reported NA, counselor-reported PA, counselor-reported NA, and TRF internalizing 
symptoms), self-reported PA significantly cross-loaded on two factors and did not load 
strongly on either factor (factor 1 loading = -0.285; factor 2 loading = -0.219, ps <.05). 
Model fit was poor when this variable was included in the model (χ2 (8) = 37.41, p = 
.000; RMSEA = .1, CFI = .958, TLI = .889); therefore, self-reported PA was excluded 
from subsequent models (further investigation demonstrated extremely restricted range of 
variability, whereby a majority of children reported high positive affect scores). 
Ultimately, the best-fitting model had a 2-factor solution (eigenvalues > 1 for the 
first 2 factors; 2.416 and 1.908, respectively; χ2 (8) = 12.01, p = .15; RMSEA = .037, CFI 
= .993, TLI = .987), with RCMAS (.699), CDI (.865), and self-reported NA (.610) 
significantly loading on factor 1 at the .05 level (factor loadings in parentheses), and TRF 
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(.856), counselor-reported NA (.730), and counselor-reported PA (-.630) significantly 
loading on factor 2 at the .05 level. This factor structure suggests an observer effect, 
given that all self-report measures loaded on factor 1 and counselor-report measures 
loaded on factor 2.  The inability to combine both self- and counselor-report measures 
into one latent variable is unsurprising given frequent discrepancy between self- and 
other- report of internalizing symptoms (Achenbach, McConaughy, & Howell, 1987). 
Exploratory efforts to create one latent variable by correlating residuals substantially 
reduced model fit.  
Confirmatory Factor Analysis 
Measurement Model 
Using a 2-factor solution as indexed by the EFA, two different CFA models were 
run on the training sample; one included counselor-reported PA, the other excluded 
counselor-reported PA. Two models were created to better examine the relevance of PA 
to the counselor-reported latent variable, in light of removal of self-reported PA per EFA 
results (above), and interest in maintaining uniformity across self- and other- reported 
indicators for the PANAS-C measure.  
The model without counselor-reported PA was not valid (i.e., residual variances 
were not significant), whereas the model with counselor-reported PA fit well (χ2 (8) = 
16.86, p = .032; RMSEA = .039; CFI = .991; TLI = .984). Thus, counselor-reported PA 
was maintained in the model. In sum, the latent variable was optimized when separated 
into two factors defined as follows: 1) internalizing-self with three indicators (α= .78) – 
RCMAS total anxiety T-score, CDI overall raw score, and self-reported NA mean score, 
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and 2) internalizing-counselor with three indicators (α= .75) – TRF internalizing T-score, 
counselor-reported NA mean score, and counselor-reported PA mean score. Standardized 
factor loadings resulting from the CFA are presented in Figure 1.  
Measurement Invariance 
The measurement model created via CFA was tested for measurement invariance 
between males and females. The first step in assessing measurement invariance is 
examining a configural model, which allows for the assessment of model fit of the 
original, fixed model compared to a model where all parameters are free to vary across 
the two groups. The configural model had acceptable fit (χ2 (16) = 21.41, p = .163; 
RMSEA = .03; CFI = .996; TLI = .992), suggesting that proceeding with testing 
measurement model invariance was appropriate. Several additional models, including 
weak, strong, strict, and partial invariance models, were examined in order to identify 
specific aspects of the model that were or were not operating similarly among the 
different groups. Weak models forced factor loadings to be the same for each group, but 
allowed intercepts and residual variances to vary. Strong models forced factor loadings 
and intercepts to be the same for each group, but allowed residual variances to vary. 
Strict models forced all aspects (factor loadings, intercepts, and residual variances) to be 
equal across groups. Additionally, partial measurement invariance models were 
constructed in order to identify which of the intercepts and/or variances differed across 
groups.  
The weak invariance model was nested within the configural model, allowing for 
comparison using a Chi Square test, where failure to reject the null hypothesis signifies 
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superiority of the weak invariance model over the configural model. The weak invariance 
model was found to be a better fit than the configural model (χ2 (20) = 25.82, p = .353; 
RMSEA = .028; CFI = .995; TLI = .993), demonstrating that constraining factor loadings 
to be equal across groups did not negatively affect model structure. Next, a strong 
invariance model was nested within the weak invariance model. In comparison to the 
weak model, the strong model was not found to be a better fit (χ2 (24) = 50.13, p = .000; 
RMSEA = .054; CFI = .979; TLI = .973). Thus, a model with constrained factor loadings 
fit better than a more restricted model that had both constrained factor loadings and 
constrained intercept values.  
Lack of strong invariance indicated that the observed means (intercepts) between 
males and females were different. Partial invariance was next examined to understand 
whether all intercepts among the various latent variable indicators were different between 
males and females, or whether only some of the intercepts differed between males and 
females. In this way, examining partial invariance allowed for some intercept constraints 
to be released while others were maintained. Chi Square tests among different indicators 
revealed that only the intercept for the TRF internalizing indicator was significantly 
different between males and females (χ2 (1) = 19.12, p = .000). Based on this 
information, the TRF internalizing indicator was released, and a modified strong 
invariance model (i.e., a strong, partial invariance model) was compared to the weak 
model. The strong partial model was nested within the weak, and when compared, was 
shown to fit better than the weak model as evident in failure to reject the null hypothesis 
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that the weak model is not an improvement over the strong partial model (χ2 (23) = 30.66, 
p = .184).  
The strong partial invariance model was then compared to a strict partial model 
and was not found to improve model fit (χ2 (29) = 47.15, p = .011). Inspection of 
differences in residuals among indicators revealed differences for the CDI measure. Chi 
Square tests among different indicators revealed that the residuals for the CDI measure 
were significantly different between males and females (χ2 (1) = 17.96, p = .000).When 
residual constraints for the CDI were released in the strict partial model, it was found to 
function better than the strong partial model (χ2 (28) = 39.52, p = .11). 
Thus, overall, the measurement model was found to have partial strict invariance, 
whereby models operated equally for males and females across factor loadings, intercept 
values, and residual variances, with the following exceptions: the TRF internalizing 
measure’s intercept was not invariant and the CDI’s residual variance was not invariant. 
This means that the CDI had different reliability for males and females and the TRF 
internalizing measure had different mean levels for males and females. Specifically, 
males had more measurement error than females on the CDI measure (male variance = 
20.16; female variance = 11.70), and females had higher mean levels than males on the 
TRF (male intercept = 47.15; female intercept = 49.27), suggesting gender specificity of 
the TRF content.  In sum, the measurement model for the current study was operating 
similarly among males and females such that the self-reported latent variable had all three 
factor loadings, all three intercepts, and two of three variances operating equally. The 
counselor-reported latent variable had all three factor loadings, two of three intercepts, 
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and three of three variances operating equally. An established rule is that so long as there 
are at least two factor loadings and two intercepts that are equal across groups, similar 
inferences about latent variables can be made for each group (Byrne et al., 1989). The 
measurement model for the current study well surpassed this metric.   
Structural Model 
The proposed structural model demonstrated good model fit (χ2 (43) = 111.26, p = 
.000; RMSEA = .046, CFI = 0.949, TLI = 0.925); fit was reduced, but was still 
acceptable (χ2 (47) = 135.37, p = .000; RMSEA = .050, CFI = .936, TLI = .904), when 
gender was added as a covariate given the gender distribution differences among 
maltreatment groups in the current sample. Distribution of age was also originally found 
to differ among maltreatment groups and was included as a covariate, but was not 
ultimately included in the final model given that, unlike gender, it did not significantly 
predict any of the outcomes, and model fit was further reduced when age and gender 
were both included in the structural model. Results for the structural model including the 
gender covariate are depicted in Figure 2, which labels significant (solid lines) and non-
significant paths (dashed lines) with their respective standardized coefficients (note: for 
maltreatment pathways, the standardized coefficient associated with standardization of 
only the latent variable was used given that maltreatment is a dummy-coded variable; all 
other paths with continuous variables list the standardized coefficient associated with 
standardization of all variables in the model). Overall, the model explained 2.5% of the 
variability in cortisol difference scores, 4.2% of variability in self-reported internalizing 
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symptoms, and 11.2% of variability in counselor-reported internalizing symptoms. 
Specific path findings are presented below.  
Cortisol Change 
Mean differences in cortisol difference scores among the three groups are shown 
in Figure 3. A main effect of maltreatment on cortisol was found such that individuals 
maltreated later in life (age five and beyond) demonstrated a higher (i.e., more positive; 
thus closer to zero) cortisol difference score value (z = 2.43, p = .015, standardized 
estimate (std est.) = .046), meaning they evinced less change in cortisol values between 
morning to afternoon, relative to nonmaltreated children. Late maltreated children also 
had higher cortisol difference values when compared to early maltreated children (z = 
2.34, p = .019, std est. = .046). Early maltreated children did not differ from 
nonmaltreated children in their cortisol difference value (p = .984). There was also a main 
effect of gender on cortisol difference values such that females had more negative 
difference score values (i.e., greater change from morning to evening) than males.  
Internalizing Symptoms 
A main effect of maltreatment on self-reported internalizing symptoms was found 
such that children maltreated earlier reported more internalizing symptoms than 
nonmaltreated children (z = 2.42, p = .016, std est. = .222). There were no differences 
between late and nonmaltreated children for self-reported internalizing symptoms (p = 
.182). When early and late maltreated children were directly compared, these groups did 
not significantly differ in level of internalizing symptoms (p = .522); see Figure 4 for 
mean differences in internalizing symptoms. A main effect of gender on self-reported 
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internalizing symptoms was found such that females had lower self-reported internalizing 
symptoms than males (z = -2.00, p = .045, std est. = -.166). There were no effects of 
cortisol slope, maltreatment, or gender on counselor-reported internalizing symptoms. 
Counselor-reported externalizing symptoms predicted both self- and counselor-reported 
internalizing symptoms whereby higher counselor-reported externalizing symptoms were 
associated with higher internalizing symptoms. There was a significant, positive 
relationship between self- and counselor-reported internalizing symptoms.   
Mediation and Moderation 
Cortisol change was not a significant predictor of either self- or counselor-
reported internalizing symptoms. Given that simple mediation requires a relationship 
between the mediator and the dependent variable (Barron & Kenny, 1986), it was 
unlikely that any of the indirect effects of the model would be significant. Indeed, of the 
four indirect effects (i.e., 1: EM  Cort * Cort  internalizing-self; 2: EM  Cort * 
Cort  internalizing-counselor; 3: LM  Cort * Cort  internalizing-self; 4: LM  
Cort * Cort  internalizing-counselor), none were significant predictors of internalizing 
symptoms (all ps >.1), reflecting lack of mediation of the relationship between 
maltreatment and internalizing symptoms by cortisol. Further, there was no direct effect 
or moderation by multigenic risk on cortisol change (main effect: z = .002, p = .998, std 
est. = .000; interaction with early maltreatment: z = -.399, p = .690, std est. = -.003; 
interaction with late maltreatment: z = 1.584, p = .113, std est. = .023). Thus, the 
functional, HPA axis-related SNPs included as part of a multigenic index in this study did 
not directly or indirectly affect daytime production of cortisol.  
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Multi-group Model 
To ensure that the structural model was operating similarly for males and females, 
a multi-group structural model in which regression paths were restricted to be the same 
across males and females was fit. This model was compared to a model where the 
regression paths were allowed to be freely estimated across groups. The partial strict 
invariance for the latent variables from the measurement model was carried forward into 
the multi-group model. Both constrained and free models had similar and acceptable fit 
indices (fit measures for both models were: χ2 (64) = 127.66, p = .000; RMSEA = 0.053, 
CFI = 0.952, TLI = 0.937). Chi Square tests comparing the less restrictive model to the 
fully restrictive model revealed that the less restrictive model did not improve model fit 
(χ2 (6) = 10.2, p = 0.12). Thus, multi-group analyses demonstrated that there were no 
differences in regression paths by gender, meaning that the structural model operated 
similarly for males and females and conclusions can be applied to both groups. 
Follow-up Analyses 
Morning and Afternoon Cortisol 
To better understand the nature of the cortisol change patterns found among 
maltreatment groups, separate linear regressions with mean, log-transformed morning 
and afternoon cortisol values as outcome variables were conducted. Maltreatment did not 
significantly predict morning (M EM = -.79; M LM = -.81; M Non = -.77) or afternoon 
(M EM = -1.06; M LM = -1.04; M Non = -1.05) cortisol values (all ps > .1). Although 
groups did not differ significantly at either time of day, as can be seen in Figure 5, there 
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was a slight lowering of morning and a slight increase of afternoon levels for later 
maltreated children relative to nonmaltreated youth.  
Severity of Internalizing Symptoms 
In light of previous findings suggesting that cortisol functioning partially depends 
on severity of internalizing symptoms (e.g., Hart et al., 1996; Cicchetti et al., 2010, 
2011), levels of internalizing symptoms in the current sample were more closely 
examined to understand whether lack of prediction of internalizing symptoms by cortisol 
in the structural model was a consequence of a relatively low level of internalizing 
symptoms within the sample. To examine this, z-scores for each indicator used for the 
self-reported internalizing latent variable (i.e., RCMAS, CDI, self_NA) and counselor-
reported internalizing latent variable (i.e., TRF, clr_PA, clr_NA) were created. The z-
scores for the three measures comprising self-reported internalizing symptoms were then 
averaged. The same was done for counselor-reported internalizing symptoms. The overall 
sample was found to have a z-score range from -1.58 to 2.98 for self-reported 
internalizing symptoms and -1.51 to 2.91 for counselor-reported internalizing symptoms. 
Despite these ranges, the mean (SD) level of internalizing symptoms was generally quite 
low for each group (self-reported internalizing: EM M  = .109 (.852), LM M = 
.061(.807), non M = -.100 (.828); counselor-reported internalizing: EM M = .085 (.043), 
LM M = -.055 (.077), non M = -.044 (.043)).  
Given that the sample had generally low levels of internalizing symptoms overall, 
a more direct examination of how the severity of internalizing symptoms might impact 
cortisol was conducted. First, symptom level (children above median vs. children below 
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median) was used to predict cortisol difference scores, controlling for gender. Symptom 
level did not significantly predict cortisol difference scores for either self-reported (F (1, 
733) = .594, p = .441) or counselor-reported (F (1, 733) = 1.20, p = .273) internalizing 
symptoms. Furthermore, symptom level had no bearing on morning or afternoon cortisol 
values for self-reported internalizing symptoms (morning: F (1, 733) = .200, p = .65; 
afternoon: F (91, 734) = .036, p = .849). Counselor-reported symptom level did 
significantly influence cortisol morning values (F (1, 733) = 6.64, p = .010), and, 
marginally, afternoon values (F (1, 734) = 3.85, p = .050) such that children with scores 
above the median had higher morning cortisol values than children with internalizing 
symptom scores below the median. 
Secondly, effects of maltreatment on cortisol were examined only among children 
with clinically-significant internalizing symptom levels (i.e., z-scores ≥ 1). Controlling 
for gender, timing of maltreatment did not predict cortisol change scores for children with 
clinical-level self-reported internalizing symptoms (F (2, 89) = 1.688, p = .191) or those 
with clinical-level counselor-reported symptoms (F (2, 81) = .394, p = .676). 
Additionally, maltreatment did not predict differences in morning or afternoon levels for 
either children with clinical-level self- or counselor- reported internalizing symptoms 
(self-report morning: F (2, 89) = 2.25, p = .11, self-report afternoon: F (2, 90) = .354, p = 
.703; counselor-report morning: F (2, 81) = 1.163, p = .318 and counselor-report 
afternoon: F (2, 81) = 1.02, p = .366).   
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Chronicity of Maltreatment 
Because it is possible that children who had an earlier onset of maltreatment may 
have also experienced more chronic maltreatment, simple descriptive statistics were 
examined. Frequencies among early and late maltreatment groups with respect to 
chronicity were plotted, as seen in Figure 6. There was more variability in number of 
development periods of maltreatment within the early maltreated group. Although modal 
number of developmental periods was 1 for each group (EM children experiencing 
maltreatment in one developmental period n = 124; LM n = 92), more children in the EM 
group experienced maltreatment during two (EM n = 82; LM n = 18) or three (EM n = 
43; LM n = 0) developmental periods, and the difference among the distribution was 
significant (χ2 (4) = 794.75, p = .000). Results demonstrate that early maltreatment also 
captures a greater range of chronicity in the current sample. 
Alternative Genetic Coding Schemes  
Given various approaches to coding genotypes prevalent in the literature, three 
additional coding schemes were tested to examine whether these approaches altered the 
structural model. As such, dominant, recessive, and additive coding schemes were 
created whereby all genotypes included in the multigenic risk score were coded either in 
accordance with a dominant (i.e., individuals carrying any risk allele were coded as “1;” 
non-risk homozygotes coded as “0”), recessive (i.e., individuals carrying two copies of 
the risk allele coded as “1;” risk heterozygotes and non-risk homozygotes grouped 
together as “0”), or additive (the three different genotypes were each given a separate 
score based on number of risk alleles – “2” for risk allele homozygotes, “1” for risk allele 
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heterozygotes, and “0” for non-risk allele carriers) model. There were no significant 
direct or moderation effects for any of the alternative coding schemes on cortisol slope 
when included in the structural model. Thus, alternative coding schemes did not alter the 
original structural model results.  
Discussion 
The current study examined the association among maltreatment, genetic factors, 
HPA functioning, and internalizing symptoms in effort to better understand mechanisms 
by which disruptions to the child-caregiver relationship negatively affect mental health. 
Overall, results highlight the complexity of development, convey the concept of 
equifinality, and reiterate the need for future longitudinal research on this topic.  
Early Maltreatment 
Consistent with the extant literature (e.g., Andersen & Teicher, 2008; Cicchetti & 
Rogosch, 2001a, b; Kim & Cicchetti, 2006; Manly et al., 2001; Widom et al., 2007), 
maltreatment was associated with an increased prevalence of internalizing symptoms in 
children above and beyond other forms of adversity (i.e., poverty). Few studies have 
focused exclusively on internalizing symptoms in maltreated, African American children 
(but see Bradley et al., 2008 and Cicchetti & Rogosch, 2014, for exceptions). Thus, 
importantly, results of the current study confirm that previous findings generalize to 
African American samples.  
Timing Specificity and Internalizing Symptoms 
As hypothesized, early, but not late, maltreatment predicted internalizing 
symptoms, suggesting time-dependent effects of maltreatment. These results echo 
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findings of several earlier studies demonstrating that children maltreated during or prior 
to the preschool years evince higher levels of internalizing symptoms than nonmaltreated 
youth and those maltreated later in childhood (Cicchetti et al., 2010; Hart et al.,1995; 
Kaplow & Widom, 2007; Keiley et al., 2001; Manly et al., 2001). Continued replication 
of these findings with the current sample points toward early-occurring maltreatment as 
being a powerful vulnerability factor for the development of internalizing symptoms, 
above and beyond other forms of risk. The first four years of life appears to be a sensitive 
period for the development of internalizing symptoms.  
Maltreatment occurring within the first few years of life presents disruption 
during a time when relationally-based developmental processes that have been implicated 
in the development of internalizing symptoms are prominent and are undergoing more 
rapid development. This suggests that there may be specificity of stage-salient 
developmental processes occurring before age 5 to internalizing symptoms, and that 
maltreatment occurring during this time may exert its effects by substantially altering 
these processes.  
Attachment is particularly salient to the early time period as it forms over the first 
year of life, and attachment patterns stabilize between 6 to 18 months of age (e.g., 
Ainsworth, Blehar, Waters, & Wall, 1978; Belsky, Rovine, & Taylor, 1984). Previous 
research has suggested attachment as a mechanism, showing that maltreated children 
have higher rates of insecure or disorganized attachment (Carlson, Cicchetti, Barnett, & 
Braunwald, 1989; Cicchetti &Barnett, 1991a), and that those with disrupted attachment 
patterns are at increased risk for internalizing symptoms (Groh, Roisman, van 
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IJzendoorn, Bakermans‐Kranenburg, & Fearon,  2012). Moreover, interventions (Child 
Parent Psychotherapy; CPP), that support secure attachments effectively reduce 
internalizing symptoms in young children (Ghosh, Ippen, Harris, Van Horn & 
Lieberman, 2011). Attachment-based interventions have also been found to normalize 
activity of stress-mediating systems (Bernard, Hostinar, & Dozier, 2015; Cicchetti, 
Rogosch, Toth, & Sturge-Apple, 2011; Dozier, Peloso, Lewis, Laurenceau, & Levine, 
2008). As such, early maltreatment may enhance risk for internalizing symptoms 
primarily through its impact on the attachment relationship and the many areas of 
development that disrupted attachment may subsequently affect, including, possibly, the 
HPA axis.   
Another explanation for maltreatment timing effects in the current study may be 
its overlap with maltreatment chronicity. Results of follow-up analyses demonstrated that 
early maltreated children in the current study experienced maltreatment across a greater 
number of developmental periods than children maltreated later in life. Chronic 
maltreatment has been considered one of the most robust predictors of general 
maladaptation (Manly et al., 2001), even when considering other maltreatment 
characteristics such as severity of maltreatment (Bolger, Patterson, & Kupersmidt, 1998). 
As such, it may be that early, chronic maltreatment is the most deleterious combination 
given the increased chances for cumulative, cascading effects and increased likelihood 
that a variety of developmental tasks are negatively affected when maltreatment occurs 
across several developmental periods. 
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It is necessary to note that speculation that early maltreated children have greater 
internalizing symptoms given disruption to foundational developmental tasks does not 
imply that later maltreated children are unaffected by their experiences or may not also 
develop internalizing symptoms. Instead, it may be that early and late maltreatment both 
affect internalizing symptoms, but do so through different pathways and on different 
timescales. As such, conceptualizing the mechanisms for early and late maltreatment 
separately could help target the most effective intervention points for these different 
groups of at-risk children.  
Informant Differences 
Notably, maltreatment effects were evident only for self-reported internalizing 
symptoms. Previous studies have differed widely in methodology of assessing 
internalizing symptomatology (e.g., use of single self-report measures, aggregate of 
multiple self-report measures, composite scores incorporating both self- and other-report, 
etc.). Many researchers have argued for the exclusive use of self-report of internalizing 
symptoms (e.g., Reynolds, Anderson, & Bartell, 1985), given that internalizing 
symptoms are emotional experiences directed within (e.g., sadness, guilt, worry), and are 
not as readily expressed through behavior as other symptoms (e.g., hitting, biting, 
stealing, hyperactivity). Findings of the current study support this recommendation, as 
discrepant findings were produced depending on informant source. As such, utilization of 
self-report measures and consideration of these measures separately from the report of 
teachers, parents, or other outside observers in future studies may help clarify the nature 
of development of internalizing symptoms and elucidate discrepant findings that 
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currently exist within the literature. Of note, it may be that the children who have 
concordance among self- and other-report measures are the children whose symptoms are 
of greatest severity, given that internal distress has risen to the level of recognition by 
other observers.  
HPA Axis Functioning  
Contrary to hypotheses, cortisol patterns across the day did not mediate the 
observed relationship between early maltreatment and internalizing symptoms. Indeed, it 
was the late and not early maltreated youth who evidence the greater disruption in the 
normal daytime cortisol pattern. The developmental psychopathology principle of 
equifinality proposes that maltreated children can travel many different pathways to the 
same pathological outcome (Cicchetti & Rogosch, 1996). Thus, one explanation for the 
lack of mediation by cortisol in the current study is that different mechanisms are 
operating at this point in time to explain the impact of early experiences of maltreatment 
on internalizing symptoms. As stated above, some of these mechanisms may include 
attachment and attachment-related phenomena, which may serve as the primary pathway 
that children experiencing maltreatment early in life travel toward internalizing 
symptoms.  
The hypothesis that HPA dysfunction, as represented by diurnal disruption, would 
mediate the relationship (suggesting its mechanistic properties) between maltreatment 
and internalizing symptoms was largely based on previous studies linking these three 
variables, in addition to the preclinical research documenting early effects of 
maltreatment on neuroendocrine function and the brain systems that control it. However, 
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it is possible that the associations found among maltreatment, diurnal patterning, and 
internalizing symptoms among children better reflect the impact of internalizing 
symptoms on cortisol, rather than vice versa. In previous studies (Cicchetti et al., 2010; 
Hart et al., 1996), both high levels of internalizing symptoms and maltreatment were 
required in order for the relationship to emerge. If HPA dysfunction comes after 
symptom onset (i.e., represents a “scar” of internalizing symptoms), lack of mediation by 
cortisol in the current study may be due to the fact that there had not been a long enough 
time from symptom onset to data collection for the effect to manifest physiologically. It 
may be that the distress caused by internalizing symptoms serves as a compounding 
stressor in the context of previous maltreatment experiences, and, together, these stressors 
contribute to HPA dysregulation over time.  
There is some support for the idea that HPA dysregulation comes after symptom 
onset. In a study of adolescents, HPA dysregulation longitudinally predicted recurrence 
of major depressive episodes much better than it predicted first onset (Vrshek-Schallhorn 
et al., 2013). Findings by Doane and colleagues (2013) also support the hypothesis that 
internalizing symptoms, in and of themselves, are contributory to diurnal blunting and 
take time to manifest physiologically. That is, Doane et al. (2013) found that blunted 
diurnal slopes were evident for adolescents who had past episodes of depression, but 
were not present for those whose depression onset was within 3 months of cortisol 
assessment. Early-maltreated children in the current study may have had more recent 
onset of symptoms, precluding any significant association between cortisol and 
internalizing symptoms to emerge. Timing of symptom onset was not considered in the 
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current study, nor was the study longitudinal in nature. Furthermore, even if some of the 
early-maltreated children had longer-standing symptoms, there may not have been 
enough of these children to be able to detect the effect.   
Alternatively, perhaps the relationships between diurnal functioning, 
maltreatment, and internalizing problems that have previously been found are more 
specific to depressive symptoms rather than internalizing symptoms, broadly. Some of 
the previous studies finding HPA dysregulation in maltreated individuals have focused on 
depression more specifically. Indeed, in a study where depressive symptoms and 
internalizing symptoms were both considered separately, maltreated children with 
clinically significant depression showed altered diurnal patterns, but maltreated children 
with internalizing symptoms, broadly, did not have any change in diurnal patterns (Hart 
et al., 1996).  
It is also possible that previous associations between maltreatment, HPA 
dysfunction, and internalizing symptoms were capturing the relationship between HPA 
dysfunction and externalizing symptoms, given the frequent overlap of internalizing and 
externalizing problems (Essex et al., 2011). Previous research has shown that diurnal 
cortisol mediated the relationship between early adversity and externalizing symptoms in 
a sample of young children (Bernard et al., 2015). There is also evidence that lower and 
flatter cortisol patterns predict externalizing symptoms in internationally adopted children 
(Koss, Mliner, Donzella, & Gunnar, 2016). The current study controlled for the effect of 
externalizing symptoms, while many previous studies have not. This may suggest that 
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diurnal blunting is associated specifically with externalizing symptoms, and may explain 
lack of mediation of internalizing symptoms in the current sample.   
Late Maltreatment 
Timing Specificity for HPA Axis Functioning 
Contrary to hypotheses, children whose maltreatment experiences began at age 5 
or later exhibited more disruption to the HPA axis in that they had less change in cortisol 
across the day. Importantly, later maltreated children also were more likely to have 
experienced maltreatment recently (between 8-12 years of age), closer to the time of 
assessment. It may be that later maltreated children in the current study demonstrated 
blunted cortisol patterns because HPA effects are better captured by current adversity 
and/or context rather than early adversity. There has been speculation about whether 
diurnal effects documented in the literature represent early adversity, current adversity, or 
both (Tarullo & Gunnar, 2006). A previous meta analysis supports recency effects of 
stress on HPA activity, demonstrating that cortisol outcomes, at least with regard to 
hyperactivity, were more pronounced for more recently occurring stress (Miller et al., 
2007). Results of the current study also suggest salience of recent life stress on diurnal 
patterning given the following: 1) children in the current study who were maltreated 
earlier in life did not evince HPA dysregulation as indexed by diurnal blunting, 2) early 
maltreated children did not evince blunted cortisol despite also having more chronic 
experiences, which have been linked to diurnal blunting (e.g., Boyce et al., 1995; 
McCormack et al., 2003), and 3) only a small percentage (20%) of the children 
maltreated before age 5 also had recent experiences of maltreatment, while a majority 
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(63%) of children whose maltreatment began at or after age 5 had recent experiences of 
maltreatment.  
It may also be that later maltreated children demonstrated more diurnal 
dysregulation due to specificity of effects of later maltreatment on brain structures (e.g., 
amygdala, hypothalamus, hippocampus, PFC) that control HPA axis functioning. For 
example, although limbic system development occurs rapidly over the first few years of 
life (Thomson & Nelson, 2001), some researchers have suggested that peak sensitivity of 
amygdala development to abuse actually occurs between ages 10-11, such that even 
modest abuse during this age has been shown to increase volume of the right amygdala in 
a dose-response fashion (Petchtel, Lyons-Ruth, Anderson, & Teicher,  2014). Thus, if the 
greatest effects on areas of the brain relevant to HPA axis control occur at later ages, this 
could explain why only individuals experiencing abuse at or after age 5 would 
demonstrate changes to HPA axis regulation in the current sample.  
Finally, the cortisol patterns of later maltreated children in the current study could 
be a byproduct of circadian-related areas of functioning that later, more recent 
experiences of maltreatment may disrupt, such as sleep. In the past, researchers have 
found associations between maltreatment and sleep disruption (Glod, Teicher, Hartman, 
& Harakal, 1997). Sleep patterns have been shown to be “protected” in younger 
maltreated children (Tininenko, Fisher, Bruce, & Pears, 2010), with issues not typically 
occurring until later developmental periods (Dahl, 1996). The nature of the disrupted 
diurnal cortisol patterns that have been associated with poor sleep (i.e., less change across 
the day, often with lower morning and higher evening levels; Palesh et al., 2008) are 
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similar to those found for the later maltreated children in this investigation. As sleep 
patterns drift, circadian patterns could follow (or vice versa). Thus, another reason that 
later maltreated children in this study may have demonstrated disrupted cortisol 
functioning could be due to the impact of maltreatment on other variables, such as sleep, 
and/or additional unmeasured characteristics of the late maltreatment group.  
Internalizing Symptoms 
There was no relationship between late maltreatment and internalizing symptoms. 
Additionally, there was no relationship between the cortisol dysfunction that later 
maltreated children exhibited and internalizing symptoms. Although it was not 
hypothesized that there would be mediation of internalizing symptoms by cortisol for 
later maltreated children, given the observed effects of late maltreatment on cortisol for 
children in the current study, the hypothesized relevance of HPA function to the 
development of internalizing symptoms, and the suggestion of possibly enhanced 
sensitivity of effects of late maltreatment on amygdala development (Petchtel et al., 
2014), it is necessary to speculate about why cortisol changes evident in the late 
maltreatment group did not, then, predict internalizing symptoms in the current study.  
A possible reason for the lack of relationship between cortisol and internalizing 
symptoms for late maltreated children could be that HPA dysregulation may not yet have 
had time to behaviorally manifest. Such “sleeper” effects would suggest that HPA 
changes may occur initially in the absence of behavioral changes, and are plausible given 
that HPA axis changes often predate behavioral changes in the opposite direction (e.g., 
delay in effect of psychotropic medication on improved depressive behavior). Heuser and 
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colleagues (1996) demonstrated that antidepressant treatment normalized HPA function 
within 1 week of administration, but symptom improvement typically requires 2-4 weeks. 
Thus, it may be that for those children whose primary path toward internalizing 
symptoms is through HPA dysfunction, the dysfunction takes time to register. If this is 
true, it would support the idea that HPA dysfunction is a mechanism that comes prior to 
symptom onset, but challenges the hypothesis that this mechanism is specific to early 
maltreated kids. If HPA mechanisms are more relevant for later maltreated kids, it could 
mean that 1) early and late maltreated kids follow different paths to internalizing 
symptoms, and 2) the late maltreated children in this study may not have had a long 
enough time since data collection for dysregulation to behaviorally manifest. In this way, 
it could be that past studies finding relationships among maltreatment, HPA dysfunction, 
and internalizing symptoms just so happened to have measured all of these things long 
after the onset of symptoms. Longitudinal studies of maltreatment, HPA function, and 
internalizing symptoms would help clarify whether HPA dysfunction better reflects risk 
for or impact of internalizing symptoms in maltreated children.    
Genetic Risk 
Contrary to expectation, there was neither a direct effect of multigenic risk on 
cortisol functioning, nor did this aspect of risk moderate the relationship between 
maltreatment and cortisol functioning, regardless of coding scheme utilized. It has been 
common in the literature to use genotype as a proxy for functional relevance, when, in 
fact, functional relevance is not well-established. Although the current study included 
only SNPs that have exhibited functional relevance, there was no observed effect on 
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cortisol functioning. However, it is important to note that, despite best efforts made to 
consider differential effects of ethnicity, gender, and tissue type when creating the coding 
scheme for the multigenic risk variable, this information was not readily available in 
many of the studies used to classify risk. Thus, it is possible that some alleles classified as 
risk were, in fact, not associated with biological functioning in the way it was presumed 
for this group of African American children.  
Additionally, genes do not operate in isolation. Although the multigenic risk score 
captured several genes involved across a biological system, it utilized an additive score to 
reflect effects across genes. While there has been speculation that even complex traits 
exhibit additive genetic variance (Hill, Goddard, & Visscher, 2008), other studies of 
anxiety and depression have demonstrated the multiplicative effects of genes (e.g., 
Cicchetti & Rogosch, 2014). As the knowledge base about the effects of single SNPs 
accumulates, future studies could use this information to assign weighted scores to better 
capture genetic risk across a variety of SNPs.   
Limitations  
This study is the first to examine concurrent associations among maltreatment, 
genetic factors, HPA axis function, and internalizing symptoms in African American 
children using structural equation modeling. Prospective assessment of maltreatment 
using DHS records and use of a classification system allowing for the examination of 
important maltreatment parameters is an incredible advantage of this study. The sample 
was large, allowing for adequate power to detect effects. The use of latent variables is 
another strength, as it allowed for a better representation of internalizing symptoms 
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among various measures while minimizing measurement error. Additionally, the use of 
an ethnically homogeneous sample allowed for population stratification issues to be 
evaded, perhaps offering a more accurate picture of genetic association for this racial 
group.   
Despite these strengths, there are limitations to consider. First, the sample, overall, 
was actually quite normative with regard to the level of internalizing symptoms, 
externalizing symptoms, and HPA axis functioning, and mean differences were generally 
small. Thus, the current sample may not be a highly representative sample of maltreated 
children, overall. More importantly, predictors explained only 4.2% of variability in 
internalizing symptoms and 2.5% of variability in cortisol functioning. Findings must 
therefore be interpreted with great caution in light of these features. Secondly, although a 
goal was to explore mechanisms using moderated mediation, the fact of the matter is that 
this is a cross-sectional study and pathways simply reflect linear associations at one point 
in time of development. Direction of relationships cannot, and should not, be implied.   
Additionally, it was not possible to fully represent the diurnal pattern given that 
samples were not collected at wake or at bedtime. Although this would have been 
optimal, the characteristics of this very low SES sample makes home collection of 
salivary samples a difficult task. That is, the disorganization that often accompanies 
families living in poverty can introduce a range of collection error problems (e.g., time 
variation, failure to properly store samples following collection, etc.). Thus, having a 
consistent collection time and storing procedure in the context of the summer camp, 
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though not allowing for examination of the full diurnal picture, may actually have 
provided a more accurate representation than home-based assessment.  
Information on wake-up time was also not obtained, precluding the possibility of 
controlling for this variable in analyses. Wake-up time is relevant to the daytime 
production pattern given that morning levels are higher after awakening due to the CAR; 
thus, morning levels are more so related to the time a child awoke rather than the 
chronological time of day. As such, without controlling for time of wake, morning values 
used in the current study may vary as a function of a child’s wake-up time rather than due 
to their maltreatment status, thereby influencing associations of late maltreatment with 
cortisol difference scores. It is unlikely that this is the case, however, given that this 
possibility would have required the entire group of later maltreated children to have 
woken up much earlier in the day than the other groups of children. 
It was also not possible to control for other factors known to influence HPA axis 
functioning, such as pubertal status or use of medication such as acetaminophen, oral 
contraceptives, and psychotropic agents. Children’s cortisol levels increase during 
puberty (Gunnar,Wewerka, Frenn, Long, & Griggs, 2009; Stroud et al., 2009), and 
medication use has been shown to affect stress hormone levels. With relevance to the 
current study, antipsychotics have been specifically linked to flatter diurnal rhythms in 
children regardless of risk-status (Hibel, Granger, Cicchetti, & Rogosch, 2007). Such 
agents could, thus, have introduced error variance into the current investigation and 
impacted results especially if more children in the late maltreatment group were 
disproportionately utilizing antipsychotic or other medications. Furthermore, pubertal 
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status may have similarly confounded the observed association of maltreatment and 
cortisol production across the day. Although a majority of children in the study were 
between the ages of 8 and 10, some of these children and those that were closer to the 
maximum age of 12, may have already entered the pubertal stage. This is possible given 
that early puberty is more likely to occur in African Americans, especially girls (Herman-
Giddens et al., 1997). However, despite lack of pubertal assessment, age was considered 
and did not change the findings when included in the structural model. Nonetheless, age 
is not equivalent to pubertal status, and both puberty and medication use should be 
considered in future projects in effort to best understand HPA function and stress-related 
vulnerability.  
Conclusions and Future Directions 
Development involves complex, dynamic, interactive systems that cascade and shift 
across the lifespan. Maltreatment introduces a potent pathogen into the developmental 
process and can have far-reaching effects. Two such implications for maltreatment on 
development includes internalizing symptoms and alterations to the typical circadian 
process of the HPA axis, depending on characteristics of maltreatment including timing, 
chronicity, and recency, as revealed in the current investigation. There are numerous 
pathways a child may follow toward both internalizing symptoms and HPA axis 
dysfunction and a host of complications that can follow the onset of each. Only through 
longitudinal studies, and continued preclinical research efforts, can a better understanding 
of the antecedents and consequences of internalizing symptoms and diurnal disruption 
following or preceding experiences of maltreatment be attained. Such studies will help 
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clarify the nature of development and, ultimately, could help guide preventive 
interventions.  
In the context of future studies, it will be of utmost importance for researchers to 
embark upon prospective, longitudinal examinations of maltreatment beginning as early 
in life as possible. Critically, these designs should repeatedly assess psychiatric 
symptoms (both internalizing and externalizing) as well as other forms of current life 
stress. Additionally, multiple assessments of HPA function across time will be 
particularly fruitful. Probing multiple aspects of HPA functioning (i.e., diurnal patterns, 
CAR, reactivity to/recovery from pharmacologic challenge, and reactivity to/recovery 
from psychosocial challenge) at multiple time points could help clarify age-related 
patterns associated with the different aspects of the HPA axis and delineate the nature of 
involvement of various levels of the system (e.g., effects at the level of the pituitary, 
adrenal, etc.). Finally, integrative models that consider the dynamic role of other 
proposed mediating variables at multiple levels (e.g., early attachment, peer relationships, 
social support, self-esteem, etc.) will add to our knowledge base regarding the ways by 
which factors induce or protect against vulnerability to internalizing symptoms following 
experiences of maltreatment, and will help inform treatment and prevention of these 
problematic disorders.  
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Tables 
Table 1. Demographic Characteristics  
 
 
 
Note. EM = early maltreatment; LM = late maltreatment; Non = nonmaltreated; ANOVA 
= analysis of variance. Significant differences in age and gender by group: LM children 
were significantly older; more female children belonged to the Non group. Differences 
resulted in both age and gender being controlled for in analyses. However, because age 
was not a significant predictor of any outcome variables when included in the structural 
model, and because structural model fit was reduced when age was included, age was not 
ultimately entered into the final structural model. 
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Table 2. Glossary of Genetic Terms 
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Table 3. Correlations Between Latent Variable Indicators and Other Study Variables 
 
Note. EM = early maltreatment; LM = late maltreatment; Gene risk = multigenic risk 
score; Cort change = cortisol change across the day; RCMAS = Revised Checklist for 
Manifest Anxiety Scale (overall T-scores); CDI = Children’s Depression Inventory (total 
raw scores); Self_NA = Self-reported negative affect (mean score) of the Positive and 
Negative Affect Schedule-Child version (PANAS-C); TRF = Teacher’s Report Form 
counselor-reported internalizing symptoms (overall internalizing T-scores); Clr_PA = 
counselor-reported positive affect (mean score) of the PANAS-C; Clr_NA = counselor-
reported negative affect (mean score) of the PANAS-C; Ext = counselor-reported 
externalizing symptoms (overall externalizing T-scores of the TRF). N = 716 (range = 
716-739 due to missing variable data).  
† p ≤ .10, * p ≤ .05, ** p ≤ .01, *** p ≤ .001. 
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Table 4. Genetic Coding Summary with Genotype Frequencies by Maltreatment Group 
 
 
 
Note. HWE = Hardy Weinberg Equilibrium; reported HWE p-values apply to genotype 
frequencies across the maltreatment groups.  
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Figures 
 
Figure 1. Confirmatory factor analysis final measurement model with standardized factor 
loadings. Note. RCMAS = Revised Checklist for Manifest Anxiety Scale (overall T-
scores); CDI = Children’s Depression Inventory (total raw scores); Self_NA = Self-
reported negative affect (mean score) of the Positive and Negative Affect Schedule-Child 
version (PANAS-C); Clr_NA = counselor-reported negative affect (mean score) of the 
PANAS-C; Clr_PA = counselor-reported positive affect (mean score) of the PANAS-C; 
TRF = Teacher’s Report Form counselor-reported internalizing symptoms (overall 
internalizing T-scores). Fit Indices: χ2 (8) = 16.86; RMSEA = .039; CFI = .991; TLI = 
.984. ***p ≤ .001. 
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Figure 2. Structural equation model of maltreatment as a predictor of internalizing 
symptoms, controlling for gender. Note. EM = early maltreatment; LM = late 
maltreatment; polyrisk = multigenic risk score; cort = cortisol difference across the day; 
Int_S = self-reported internalizing symptoms latent variable; Int_Clr = counselor-reported 
internalizing symptoms latent variable; Ext_Clr = counselor-reported externalizing 
symptoms (TRF T-scores). Significant (solid lines) and non-significant paths (dashed 
lines) are labeled with their respective standardized coefficients. Fit indices: χ2 (47) = 
135.37; RMSEA = .050, CFI = .936, TLI = .904. * p ≤ .05, ** p ≤ .01, *** p ≤ .001. 
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Figure 3. Mean cortisol difference scores among maltreatment groups. Note. EM = early 
maltreatment, LM = late maltreatment, Non = nonmaltreated. Values represent change in 
cortisol across the day as indexed by the mean (across 5 days), log-transformed morning 
value subtracted from the mean, log-transformed afternoon value. Higher scores (more 
positive, closer to zero) represent less change from morning to afternoon. Significant 
differences exist among groups such that LM have higher scores (less change) compared 
to EM (z = 2.34, p = .019, std est = .046) and compared to Non children (z = 2.43, p = 
.015, std est = .046). EM children did not differ from Non in their cortisol difference 
value (p = .984). 
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Figure 4. Group differences in self-reported internalizing symptoms. Note. EM = early 
maltreatment, LM = late maltreatment, Non = nonmaltreated. Indicator values used for 
the self-reported latent variable (i.e., RCMAS T-score, CDI raw score, PANAS_NA 
mean score) were z-scored; mean of z-scores among the three indicators are depicted in 
the figure.  
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Figure 5. Mean morning and afternoon cortisol values and change patterns across the day 
by maltreatment group. Note. EM = early maltreatment, LM = late maltreatment, Non = 
nonmaltreated. Groups did not differ significantly at either time of day (EM vs non 
morning: z = -.609, p = .543, std. est. = -.011; LM vs non morning: z = -1.453, p = .146, 
std. est. = -.034; EM vs non afternoon: z = -.418, p = .676, std. est. = -.006; LM vs non 
afternoon: z = .638, p = .524, std. est. = .013). However, there was a slight lowering of 
morning and a slight increase of afternoon levels for LM children.  
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Figure 6. Overlap of maltreatment timing and number of developmental periods across 
which maltreatment occurred (chronicity). Note. Ndevprd = number of developmental 
periods (chronicity). More children in the early maltreatment group experienced 
maltreatment during two (EM n = 82; LM n = 18) or three (EM n = 43; LM n = 0) 
developmental periods. The difference between distributions was significant (χ2 (4) = 
794.75, p = .000). 
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